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CHAPTER I 
INTRODUCTION -
Pseudomonas cepacia is a gram negative nonfermenta-
tive bacillus also referred to in the past as Pseudomonas 
multivorans, King group E0-1, and Pseudomonas kingii. A 
number of investigators have done biochemical, antibiotic 
susceptibility and DNA homology studies on P._ cepacia. 
Since the late 1960 • s, literature citing P. cepac·ia as an 
organism causing nosocomial infection outbreaks in hospitals 
throughout the world has been increasing. 
B~ochemical methods currently used for identifica-
tion of this organism are time-consuming and errors can 
readily occur during laboratory manipulations. Altho~gh 
serological methods have proven useful for the rapid identi-
fication of a variety of other human pathogens, very little 
work has been done with respect to the antigenic character-
istics of this organism. The purpose of this study was to 
perform a detailed biochemical and serol~gical analysis of 
Pseudomonas cepacia and to determine whether differences in 
serological reactivity can be correlated with differences 
in antibiotic susceptibility and biochemical reaction pat-
terns among diverse strains of P. cepacia. 
1 
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A. Pathogenicity 2 
Group A streptococci and staphylococci were the ma-
jor pathogens encountered in hospital-associated infections 
before the antibiotic era began in the 1940's (72). Follow-
ing the introduction of sulfonamides, penicillins, tetra-
cyclines and erythromycin, there was a considerable de-
crease in death-rates from major infections such as bac-
teremias. Antibiotic-resistant staphylococci began to 
emerge as a major hospital problem so that the 1950's came 
to be called the "staphylococcal decade" (72). In the 
early 1960's penicillinase-resistant semisynthetic peni-
cillins came into use and, about the same time, epidemic 
staphylococcal disease within hospitals appeared to subside. 
Since then, another phenomenon has been emerging. There 
has been a striking increase in nosocomial infections 
caused by gram negative bacilli (72). Studies in the mid-
1960's showed Staphylococcus aureus as the cause of 34% of 
nosocomial infections (72); by 1975, the frequency of noso-
comial S. aureus infections had dropped to 10.4% (Center for 
Disease Control: National Nosocomial Infections Study Report, 
Annual Summary 1975, Issued October 1977). Gram negative 
rods, particularly Escherichia coli and members of the Kleb-
siella-Enterobacter group and Pseudomonas species are now 
the pathogens in more than 70% of nosocomial infections. A 
1970 survey of community hospitals showed that 7% of 90,000 
patients developed nosocomial infections and pseudomonads 
accounted for 10% of these hospital-acquired inf;ections (26) . 
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The s.teady increase in the isolation of gram negative 
rods, especially the Pseudomonas sp. , as ·opportunistic path-
ogens appears to correlate with a general increase in the 
numbers of debilitated or immunologically compromised pa-
tients found in hospitals today. These pseudomonads, which· 
are generally low grade in virulence, have a predilection to 
cause potentially serious disease in patients with burns, 
cancer (especially acute leukemia), cystic fibrosis, nar-
cotic addiction and immune deficiency syndromes. A number 
of unusual Pseudomonas sp. have been shown to be ·a signifi-
cant cause of infection in patients receiving prolo~ged 
courses of antibiotics, immunosuppressive drugs, steroids, 
cytotoxic agents or inhalation therapy (26). These organ-
isms can also be a threat to patients undergoing respira-
tory or urinary instrumentation and to recipients of vari-
ous transplants and prostheses (23). Newborns as well as 
the elderly are likely candidates to develop infections 
with these opportunistic pathogens. 
Among the unusual saprophytic Pseudomonas sp. which 
are being isolated in hospitals as potential nosocomial path-
ogens, one of the most commonly isolated is Pseudomonas 
cep'acia. P. cepacia was originally described as a plant 
pathogen causing onion bulb rot (8). In 1953 (68), and then 
again in 1961 (65), this organism was isolated from cases of 
septicemias and fatal bacterial endocarditis after cardiac 
P' 
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surgery, intravenous therapy, and genitourinary tract mani-
pulations. One problem in evaluating the role of P. cepacia 
as a pathogen is the fact that the virulence of strains of-
the organism may be quite variable. Some strains of P. 
cepacia appear to act as primary invaders,_since the organ~ 
ism has been isolated as the etiological agent in a sub-
acute necrotizing granulomatous lung lesion resembling me~. -
lioido s'i.s in a previously healthy young male (17) . P. cepa-
cia strains have also been isolated as the pathogen in foot 
lesions from healthy soldiers training or working in the 
swamplands of Florida and the Mekong Delta in Vietnam (69). 
In general, however, the organism seems to have low inva-
siveness and to require a portal of entry such as intra-
venous cannula or bladder catheter to cause deep infections 
(23). 
Between 1960 and 1970, P. cepacia was recovered from 
septicemias (32,46,55,76), pneumonitis (17,75), wound infec-
tions (3,32), contaminated detergent solutions in urinary 
catheter kits (35,48), renal calculi (62), urinary tract 
infections (32,35,48), and from soil and water (2). In 
some patients, infections caused by this organism resolved 
without any treatment. However, in debilitated patients, 
or in patients with compromised defense mechanisms, the in-
fections could only be eradicated with the use of proper 
antibiotics (75). 
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Recently, there has been a marked increase in noso-
comial infections caused by P. cepacia. Ultrasonic inhala-
tion therapy nebulizers, which have ·a water reservoir, have 
occasionally been found to be colonized with P. cepacia (28). 
The optimum growth rates and maximum population yields for 
P. cepacia in distilled water occur at 37°C but high popu-
lation levels of 106-10 7 organisms/ml are maintained at 
temperatures of 18-42°C (11). It is not surprising, then, 
that contaminated distilled water was found to be the 
source of infection in several studies (9,61,64). Contami-
nation of inhalation therapy equipment has led to a lung 
abscess in a diabetic patient (59), and to pneumonia fol-
lowing cardiac surgery (75). P. cepacia has been recovered 
from a bacteremia occurring in a hydrocephalic child after 
insertion of a Holter valve (4), from a meningitis follow-
ing a meningomyelocele repair (18), and from a case of 
septic arthritis following injection of contaminated 
methylprednisolone into the ankle (42). 
There has also been an increased incidence of iso-
lation of P. cepacia as the causative agent of endocarditis 
in heroin addicts (16,50,51). The broad resistance of P. 
cepacia to antibiotics, particularly to bactericidal a-
_gents, hinders the achievement of sufficient levels of an-
tibiotic in the blood to eradicate organisms implanted 
within vegetations, either natural heart valves or on 
prosthetic valves (60). Skin lesions suggestive of ecthyma 
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gangrenosum, whi.ch is usually associated wi.th -infection with 
P. aeruginosa, have been reported in two of these heroin ad-
diets with P .. cepacia endocarditis (44, 51). It was suggested 
that P. capacia may also be able to produce bacterial toxins 
which would cause the cutaneous vasculitis (~4}. However, 
toxin production by P. cepacia has not been extensively 
studied, to date. 
P. cepacia strains are able to destroy preservative 
additives, such as methyl propyl-p-hydroxy benzoates, added 
to cosmetics (15), thus making colonized cosmetics a poten-
tial danger to debilitated people. Photoreactivation of P. 
cepacia strains after ultraviolet irradiation used to steri-
lize industrial and potable water supplies has also beeri 
reported as a potential source of contamination if such 
ultraviolet-treated ~vater is used in the hospital environ-
ment (12} 
B. Taxonomy 
P. cepacia is an aerobic unicellular gram negative 
bacillus which has been assigned to the pseudomallei group 
in the family Pseudomonadaceae (33). Major nutritional char-
acteristics which are found useful in disti~guishing P. 
cepacia from other members of the Pseudomonadaceae are: 
utilization of a wide variety of monosaccharide and disac-
charide sugars, variable oxidase activity, accumulation of 
poly-a-hydroxybutyrate, production of lysine decarboxylase 
and the absence of arginine dihydrolase. 
p 
In the past, there has been a great deal of contro-
versy regarding the taxonomic position of P. cepacia and 
its relationship to other organisms,- including P. multi-
vorans, E0-1 King group and P. kingii. On the basis of 
nutritional studies of the phytopathogenic pseudomonads, 
Ballard et al. (2). concluded that P. cepacia is the same 
as P. multivorans. The pseudomonad E0-1 of King (40), de-
signated P. kingii by Jonsson (39), was shown by Gilardi 
(30) and Pickett (57) to be indistinguishable froni P. 
cepacia. Weaver et al. (63) also studied the fatty acid 
compositions of P. cepacia (P. multivorans) and P. kingii 
and found them to be identical. 
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When the rRNA/DNA homology groupings of the Ps·eudo-
monas sp. are examined (54), P. cepacia falls into a single 
group which includes the following organisms: P. ·cepacia, 
P. marginata, P. caryophylii, P. pseudomallei, P. mallei, 
P. pickettii, P. solonacearum. All the members of this 
pseudomallei-cepacia rRNA/DNA homology group, with the 
exception of P. pickettii are pathogens for animals or 
plants. The P. cepacia "species" vary a great deal in 
their phenotypic properties and in DNA homology. This 
indicates that a further subdivision of the species may be 
warranted. 
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C. Isolation and Identification 
1. Biochemical char'ac·teris.tics 
P. cepacia s.hares a few phenotypic characters with 
the other members of the pseudomallei.-cepacia DNA homology 
group, including: accumulation of poly-a-hydroxybutyrate as 
carbon reserve material, utilization of arginine and betaine 
as sole carbon sources and ability to grow at 40°C in com-
plex media (20). Some of the P. cepacia strains are the most 
nutritionally versatile in the genus Pseudomonas. P .. cepacia 
along with the fluorescent pseudomonads, use the e-keto-adi-
pate pathway for the degradation of various aromatic com-
pounds such as mandelate, benzoate, p-hydroxybenzoate and 
tryptophan. However, the enzymes of P. cepacia and the 
fluorescent group in the pathway are immunologically unre-
lated (54). 
P. cepacia strains are motile by means of polar 
multitrichous flagellation (one to three flagella). Many 
strains produce a conspicuous sulfur-yellow, water-soluble, 
nonfluorescent pigment in the colonies and surrounding 
medium. Some strains can also produce_ green, brown, red, 
violet or purple phenazine pigments, depending on the carbon 
source used for. growth (20,37). 
P. cepacia strains do not denitrify but they can 
produce nitrites from nitrate. Most strains are lipolytic 
and some can hydrolyze gelatin. Most P. cepacia strains can 
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use from 95 to more than 105 different organic compounds as 
sole carbon sources for growth. The optimal temperature for 
growth is about 30-35°C and they will not grow .at 4°G (20). 
2. Antibioticsusceptibility patterns 
Gilardi (31) proposed that antimicrobial suscepti-
bility can be used as a diagnostic aid in identification of 
nonfermenting gram negative bacteria. Gilardi and other 
workers (23,49,52,57) have consistently reported P. cepacia 
to be a highly antibiotic resistant organism. P .· cepacia 
strains have been found to be resistant to colistin,_genta-
micin, tobramycin, and carbenicillin, which are commonly 
used drugs-of-choice against Pseudomonas aeruginasa infec-
tions. Most strains of P. cepacia have been found to be 
sensitive to chloramphenicol and trimethoprim-sulfamethoxa-
zole w1th a lesser percentage also sensitive to nalidixic 
acid and/or kanamycin. 
3. · Purpose of this study 
a. Biochemical analysis 
The media and test conditions used in the identifi-
cation and differentiation of nonfermentative_ gram negative 
bacteria are diverse. Most clinical laboratories presently 
use one of three general schemata for identification of the 
nonfermentative bacilli. These are based on modifications 
described by Weaver et al. (74), Hugh and Gilardi (37), and 
Pickett and Pedersen (57,58). The first two use basically 
similar media and methods as originally described by Eliza-
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beth King (40) and the third of these (Pickett) uses a buf-
fered substrate method. All of these methods are time-con-
suming, vulnerable to much error during laboratory manipu-
lations and difficult to standardize. In an effort to 
find a more rapid method to identify P.cepacia strains, 
the API 20 Enteric Strip, made by Analytab Products, Inc., 
was analyzed for its ability to correctly identify diverse 
strains of P .. cepacia and to differentiate this organism 
from biochemically similar nonfermentative organisms. 
Biochemical reactions of 38 strains of P. cepacia tested 
with the API 20E micromethod were compared with results ob-
tained by testing the same strains with conventional media. 
as used by King, Weaver and Gilardi. 
b. Antibiotic susceptibility testing 
Most of the studies on antibiotic susceptibility 
patterns of gram negative nonfermentative rods (33,34,52), 
have used the Kirby-Bauer (5) antimicrobial testing method. 
Therefore, only resistance or sensitivity to the battery 
of antimicrobials tested are reported. Only a few workers 
(60) have reported minimum inhibitory concentrations 
(MIC's) for P. cepacia strains. Since P. cepacia strains 
show variable antibiograms (49) and are generally found to 
be resistant to most antibiotics by the Kirby-Bauer tech-
nique, it was thought of importance to determine the MIC 
levels that these strains of P. cepacia exhibit. There-
11 
fore, antibiograms obtained for the 38 strains·using the 
Kirby-Bauer disk diffusion method were compared with those 
derived from MIC values obtained using a micromethod 
developed by Micro-Media Systems, Inc. (1435 Koll Circle, 
#106, San Jose, Ca. 95112). 
c. Serological studies 
Serological methods have proven useful for the 
identification of many species of the Enterobacteriaceae 
(25) as well as other bacteria (73). They provide an in-
valuable tool along with antibiograms. bacteriophage typing 
and pyocin typing in epidemiological investigations. Re-
cently, for example, commercial antisera for P. aeruginosa 
strains (26) have become available and this has proven to. 
be an aid in epidemiological and clinical studies. 
Very little work has been done with respect to 
the antigenic characteristics of P. cepacia. Therefore, a 
serological study of this organism seemed to be a logical 
and necessary step. In this study, formalin-killed anti-
gens were used to immunize rabbits and prepare antisera 
against 29 P .. cepacia strains. The antisera were then 
used in agglutination studies to determine presence of 
cross-reacting antigens among the various strains. 
I,.,-
CHAPTER II 
MATERIALS AND METHODS 
A. Organisms 
Thirty-six strains of P. cepacia used for study in 
this work were all clinical isolates obtained from various 
workers in this field. The following strains were re-
ceived from Dr.R.E.Weaver, the Center for Disease Control 
in Atlanta, Georgia: B4134, B4648, B5910~ B5912, D6566, 
D6460. Dr. G.L.Gilardi from New York sent the following 
strains: 2332, 2416, 2160, 2106, 2078, 2075, 2076, 2077, 
2331, 2369, 2368, 2371. Strains B-1 and B-2 were received 
from Dr. E.J.Bottone in New York. Dr. D.Taplin from 
Florida sent us three strains: CJ62, FB96 and FB143. Nine 
strains were received from Dr. M.J.Pickett at UCLA in Cali-
fornia: Kl036, Kl021, K981, K998, Kl075, K808~ K358, K359, 
K360. Two strains were also received from the API Refer-
ence Laboratory in New York: 75-3351 and 75-2013. 
The following strains were obtained from the Ameri-
can Type Culture Collection (ATCC) to be used as reference · 
strains: P. aeruginosa #10145, P. cepacia #10856~ P. 
cepacia 1!25416, P. maltophilia .ffl3637, P. ·fluore·scens 
.ffl3525, Flavobacterium meningosepticum .ffl3253, Acineto-
bacter calcoaceticus .fj23055, Xanthomonas campestris .ff6402, 
12 
, 
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P. stutzeri #17588, and Achromobacter xyloseoxidans #27061. 
Two strains, LU2800 and LU3468, were obtained from 
clinical specimens from the Clinical Microbiology Labora-
tory of Foster G. McGaw Hospital of Loyola University of 
Chicago. 
B. Isolation and Maintenance 
All of the strains used in this study were isolated 
on BBL Blood agar plates (Trypticase Soy Agar with 5% de-
fibrinated Sheep Blood) and were incubated at 35°C in 
incubators flushed with 100% co2 (Ohio Medical Products) 
regulated to maintain a constant 5% co2 atmosphere. Al-
though increased carbon dioxide tension was not an absolute 
requirement for the growth of these organisms, it did en-
able us to obtain larger yields for subsequent biochemical 
studies. The organisms were subcultured to fresh Blood 
agar plates everyday for short-term maintenance of their 
viability. 
For long-term maintenance, all of the organisms used 
in this study were quick-frozen in defibrinated sheep blood 
utilizing a modified CDC Quick-freeze technique (41). 
Disposable glass tubes (16Xl00 mm) with plastic caps were 
autoclaved and then appropriately labeled. One ml of de-
fibrinated sheep blood was sterilely added to each tube. 
A Dacron swab (Scientific Products) was used to remove as 
much growth as possible from a 24-hour culture of the or-
14 
ganism on a Blood agar plate and a heavy suspension of the 
organism was made in each tube. Prior to. freezing. each 
tube was checked for contamination by subculturing onto a 
Blood agar plate which was incubated overnight at 35°C in 
5% co2 . Each tube was then quick-frozen in a freezing bath· 
consisting of a metal container filled with acetone (100 ml) 
to which a small piece of dry ice had been added. The 
frozen tubes were then placed in a freezer and maintained at 
-55°c. 
C. Biochemical Tests According to Conventional Methods ·as 
· Used by King, Weaver, Gilardi, Pickett and Others. 
Difco OF basal medium (prepared according to manu-
facturer's instructions) with 10% added dextrose, sucrose, 
maltose, lactose, xylose, mannitol or rhamnose was used 
to test for carbohydrate utilization (27,36). OF basal 
medium without carbohydrate was used as the control with 
each set of tests. The transfer broth used to inoculate 
the carbohydrates was 2.5 ml of Trypticase soy broth (Difco 
TSB, prepared according to manufacturer's instructions). 
A Dacron swab was used to make a heavy (milky) ·suspension 
of a 24-hour old culture of the organism taken from Blood 
agar plates. The oxidation tubes were inoculated with· 
approximately 0.3 ml of the bacterial suspension by stab-
bing with a pasteur pipet and releasing the suspension 
slowly while withdrawing .the pipet from the medium. 
, 
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The reactions of the OF carbohydrates were read after 
48 to 72 hours of incubation at 35°C. A change in the 
color of the bromothymol blue indicator in the semi-solid 
OF media from green to yellow at the surface of the medium 
denoted acidity (A) due to oxidation of the carbohydrate. 
A change in color of the media from green to blue (K) 
denoted alkalinization due to deamination of the peptones 
in the basal medium. 
The oxidase test was performed by rubbing a colony 
from a Blood agar plate onto a filter paper which had been 
premoistened with a drop of Kovac's reagent-1% tetramethyl-
p-phenylenediamine dihydrochloride (Eastman) and then ob-
serving for development of a purple color within 10 seconds 
(70). 
Catalase production was tested for by placing a drop 
of 30% HtOz on a glass slide, adding a loopful of the 
organism, and checking for the production of bubbles (53). 
Growth on MacConkey agar was detected by inoculating 
~~cConkey agar slants (Difco, prepared by manufacturer's 
instructions) and MacConkey agar plates (BBL) with a six-
hour TSB culture of the organism and incubating at 35°C 
(33). The slants and the plates were checked for growth 
at 24 and 48 hours. 
ONPG disks (Difco) were used according to manufac-
turer's instructions to test for the presence of e-n-
galactosidase. 
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Six.,..,hou:r TSB. cultures were used to inoculate Trii>le 
Sugar Iron CI'SI}, urea, citrate and· tryptone medi.a (Di:fco, 
prepared according to manufacturer'-s instruction}. TSI 
agar slants were used to determine the ability of an organ~ 
ism to attack lactose, sucrose and glucose with or without 
the production of gas, along with the determination of pos ... 
sible hydrogen sulfide (H2S} production from sodium thio-
sulfate (25}. Citrate agar slants were inpculated to de-
termine a certain bacteria's ability to utilize citrate as 
its sole source of· carbon (_66). Urease agar is used to de-
termine an organism's ability to produce the ·enzyme urease, 
which splits urea, forming· two molecules of ammonia (14). 
TSI, urea and citrate were checked at 24 and 48 hours. 
Xylene and Erlich's reagent (53) were added to the tryptone 
broth after 48 hours to test for indole production (70). 
Motility was determined in Difco's Motility Test 
Nedium, prepared according to manufacturer's instructions. 
Growth was taken from a 6-hour TSB culture with an inocu-
lating needle, the media was stabbed half way down and in-
cubated at 25°C. Motility (indicated by diffuse growth 
emanating from the stab line in the semi-solid medium) was 
checked for at 24 ·and' 48 hours: (25). 
Esculin hydrolysis was detected by inoculating bile 
esculin s.lants (Difco, prepared according to manufacturer's 
instructions} with a heavy TSB suspension of the organism. 
Organisms able to hydrc:>'lyze esculin t~rned the· bile- escU. ..... 
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lin slant black in 24 to 48-hours (33): 
Gelatin liquefaction was detected with gelatin strips 
(Key Scientific) following manufacturer's instructions. A 
heavy suspension of the organism was made in 1 ml of dis-
tilled water in a 13 X 100 mm tube. A gelatin strip was 
added and the tube was incubated at 35°C for 24 to 48 
hours. Liquefaction was shown by separation of the_ gelatin 
from the strip resulting in the appearance of the blue sup-
porting base. 
Nitrate broth (Pfizer) was used to detect the ability 
to reduce nitrate to nitrite. To a 48-hour nitrate broth 
culture of the organism one drop of 6M HCl was added fol-
lowed by 12 drops of nitrate reagent (Key Scientific). The 
development of a pink color was a positive test. A small 
amount of zinc dust was added to all negative tubes to 
check for denitrification of nitrate to nitrogen gas. If 
still no color developed nitrate was denitrified to nitrogen 
gas or other products (37). 
F/N (Fluorescence-denitrification agar) slants (Key 
Scientific) were used to detect the ability to reduce 
nitrate and/or nitrite to N2 gas (56). The media was used 
according to manufacturer's instructions. The slants were 
inoculated with 0.3 ml of transfer broth and the butts were 
stabbed with an inoculating needle. Gas bubbles in the 
butt of the F/N slant showed the ability of the O!ganism 
to break nitrate and/or nitrite down to nitrogen gas. F/N 
slants were also used to detect the presence of auto-
fluorescence. After 48 hours of incubation at 35°C all 
tubes were placed under a UVSL~25 Mineralight in a dark 
room and checked against a positive (~. fluorescens) and 
a negative (P. nialtophilia) control. 
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Gluconate oxidation was detected by adding a loopful 
of growth of the organism into a 13 X 100 mm tube contain-
ing 1.5 ml of sterile water and a gluconate substrate tab-
let (Key Scientific} and incubating at 35°C for 48 hours. 
Following manufacturer's instructions for performance of 
this assay a Clinitest (Ames) tablet was added to detect 
the presence of reducing sugars. A negative test was de-
velopment of a blue color and a positive test ranged from 
green to dark orange. 
Hemolytic activity of the organisms was de.tected on 
sheep Blood agar plates incubated at 35°C under 5% co2 (33). 
Growth on Salmonella-Shigella (SS) agar was detected 
by streaking the organism on Pfizer SS agar and observing 
for growth after a 24-48 hour incubation at 35°C (27), 
The production of phenylalanine deaminase was de-
tected by inoculating Difco phenylalanine slants (prepared 
according to manufacturer's directions) with a few drops 
of a 6-hour TSB culture and incubating at 35°C. After 24 
hours the slant was flooded with 10% (w/v) ferric chloride 
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solution and observed for the development of a green color 
(24). 
Accumulation of poly-13-hydroxybutyrate Q?BHB) was 
determined by staining organisms taken from 24-hour old 
cultures grown on Blood agar plates with Sudan Black (7,27}. 
The stain was prepared by dissolving 0,3.g of Sudan Black 
B Olarleco) in 100 ml of 70% ethanol and allowing the 
solution to stand overnight before use. A thin smear of 
the organism was made and heat fixed. The slide was 
flooded with Sudan Black, left for ten minutes, drained 
and blotted dry. The smear was washed and cleared with 
xylol and counterstained with 0.5% aqueous solution of 
safranine (Difco) for 10 to 15 seconds. The highly re-
fractile poly-a-hydroxybutyrate granules in the cells 
appeared blue-black, whereas the rest of the cell stained 
pink, when examined under oil immersion with a 100 .X:: 
objective. 
Deoxyribonuclease (DNAse) activity was detected by 
making heavy streaks of the organisms on DNAse Test agar 
(Difco} incorporated with 0.01% (w/v) of toluidine blue. 
After 24-48 ·hours of incubation at 35°C a change in the · 
indicator to pink around the growth was observed (33). 
Lecithinase production was tested by observing for a 
white precipitate around 48-hour growth on a 'l'SA plate 
supplemented with 10% (w/v) of Egg Yolk Enrichment (BBL) 
(33). 
Lipase activity was tested for by observing for an 
irridescent sheen around 48-hour growth on t~e egg yolk 
enriched TSA plates (33). 
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Casein hydrolysis was determined by observi~g for a 
clear zone around 48-hour growth of the organism on TSA 
plus 10% (v/v) of Skim Milk Powder (BBL) (33). 
Growth at 42°C was determined by inoculating pre-
heated Brain Heart Infusion Agar (BHIA, Difco) slants and 
Trypticase Soy Broth with one colony of the organism and 
incubating in a 42 + 0.05°C incubator for 24 hours (33). 
Yellow pigment production by the organisms was ob-
served on a variety of media including TSI slants, Blood 
agar plates and Mueller-Hinton plates which were used for 
determining antibiotic 'susceptibilities. 
Lysine decarboxylase and ornithine decarboxylase 
production were detected by adding 1-2 drops of a heavy 
suspension in the organism in saline to a 13 X 100 mm tube 
(one for each test) containing 1 ml of distilled water and 
a lysine decarboxylase test tablet (Key Scientific) or an 
ornithine decarboxylase test tablet (Key Scientific),re-
spectively, (as directed by manufacturer's instructions). 
After 24 hours of incubation at 35°C 2 drops of 40% KOH 
followed by 1 ml of ninhydrine (Key Scientific} in chloro-
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form were added to each tube. Development of a violet 
color in the lysine decarboxylase test and a rose-red col-
or in the ornithine decarboxylase test in the lower chloro-
form layer in 10 to 15 minutes was considered a positive 
test. 
D. Bi"ochemical Tests Used in the API 20E Me-thod 
The API 20 Enteric Strips used in this study were 
obtained from Analytab Products, Inc., Plainview, New York. 
The. API 20E System is a standardized, miniaturized version 
of conventional procedures for the identification of 
Enterohacteriaceae and other gram negative organisms. The 
system is a strip of plasticized paper consisting of 20 
microtubes containing dehydrated media. The media are 
reconstituted by adding a bacterial suspension and then 
the strips are incubated so that the organisms could react 
with the contents of the tubes. Twenty.tests are available 
on the strip~ arginine dihydrolase, citrate, H2s, urease, 
tryptophan deaminase, indole, Voges-Proskauer,_ glucose, 
mannitol, inositol, sorbitol, rhamnose, melibiose, ONPG, 
ly~ine decarboxylase, arabinose, amygdalin, ornithine 
decarboxylase •. gelatinase and sucrose. Reactions of seven 
additional biochemical tests are used to help in the iden-
ti:f;ication of non'fermentative rods with this system. The 
reduction of nitrate to nitrite or complete denitrifica-. 
tion to nitrogen gas is te;ted for on the test st-rip in 
~--
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the glucose microtubule which has potassium nitrate added 
to it. Conventional nitrate reagents are used with the 
tests. Hotility of the organisms is tested according to 
conventional means using 0.3% semisolid agar-or the hang-
ing drop method. An organism's ability to grow on Mac~ 
Conkey agar produce cytochrome oxidase and oxidize or fer-
ment OF dextrose are the four other reactions considered 
in the identification. These four tests are performed ac-
cordi~g to the conventional methods. 
In this study the API 20E strips were inoculated and 
read as described in the manufacturer's instructions except 
that the inoculum used was prepared as follows: two 24-
hour old colonies on Blood agar plates were touched with 
the tip of a sterile wooden applicator stick, the stick was 
inserted into a tube with 5 ml of sterile saline, pH 
5.5-7.0 and then the stick was rotated in the saline to 
release and disperse the organisms. The microtubes were 
then filled with the inoculum (approximately 106 bacteria/ 
ml} and incubated for 48 hours at 35°C in an incubatorunder 
atmospheric conditions. The same lot of API 20E strips was 
used throughout this study. 
The computerized API Analytical Profile Index,which· 
lists the biochemical patterns associated with each Ente-
robacteriaceae species and other gram negative organisms, 
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is used to compa-re derived biochemical test res.ults with 
and arrive at a genus and species identification of the 
test organism. This computerized index is continuouslr 
updated b~ API to include more and more possible biochemi-
cal patterns for gram negative bacilli as they discover 
new strains. 
E. Antibiotic Susceptibility Testing 
1. Kirby-Bauer disk diffusion method 
Antibiotic susceptibility testing on all thirty-
eight s.trains of P. cepacia was performed using th_e stan-
dardized Kirby-B.auer, single disk diffusion method (36). 
A few colonies (three to eight) of the organisms to be 
tested were transferred with a wire loop from a Blood 
agar plate to a test tube containing 2.5 ml of Trypticase 
s.oy broth. A 2-5 hour TSB culture of the organism was 
then diluted with saline to the density equivalent to that 
of a 0.5 McFarland standard,approximately 1.5 X 108 bac-
teria/ml (53). A sterile Dacron swab was theri immersed 
. into the broth culture, rolled against the side of the 
tube to remove excess liquid, and then used to swab a 150 
mm Mueller-Hinton (_BBL) plate (5-6 mm in depth) in three 
plan~s. Care was taken to cover the entire plate evenly. 
The following antibiotics were dropped onto the seeded 
Mueller-Hinton plates for each organism: one dispenser in-
eluded (a} ampicillin llO meg .. Pfizer) • (b) cephalothin 
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(30 meg, Pfizer), (c) chloramphenicol (30 meg, :Pfizer), 
(d) tetracycline (30 m~g. Pfizer). (e)_ gentamicin (10 mcg 1 
Pfizer), (f) kanamycin (30 meg, Pfizer), (g) carbenicillin 
(100 meg, Pfizer), (h) colistin (10 -meg, Pfi:zer), (i) tobra--
mycin (10 meg, Pfizer); another dispenser included (a) nitrG:-
furantoin (300 meg, Pfizer), (b) trimethoprim (1. 25 meg) 
and sulfamethoxazole '(23. 75 meg, Pfizer). (c) nalidixic acid 
(30 meg, Pfizer), (d) vancomycin (30 meg, Pfizer), (e) oxa""' 
cillin ( 1 meg, Pfizer), (f) erythromycin (15 meg, Pfizer). 
(g) penicillin G (10 units, Pfizer), (h) clindamycin 
(2 meg, Pfizer), (i) amikacin (10 meg, Pfizer), and (j) ti-
carcillin (75 meg, BBL). The plates were incubated over-
night at 35°C without co2 . Sensitivity or resistance to 
each antibiotic was determined by measuri~g the size of the 
zone of inhibition around each disk. These zone sizes were 
compared to the standardized required zone sizes for sensi-
tivity to each antibiotic as determined by Kirby and 
Bauer (5). Standard control organisms o~ known suscepti-
bility (Stock cultures of Staphylococcus aureus ATCC 
#25923, Escherichia coli ATCC #25922 and Pseudomonas 
aeruginosa ATCC #27853 were tested with each batch of 
sensitivities as a check on the activity of the disks and 
on the reproducibility of the tests. 
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2. Micro-Media microtiter antibiotic di.luti:on· stisce'pti-
bility testing· method 
Minimum inhibitory concentrations of nine antibiotics 
against the 38 strains of P. · cepacia were determined using 
microdilution MIC test panels prepared by Micro-Media 
Systems, Inc. The gram negative test panel used in these 
studies consists of a microtiter "V" well plate containing 
antimicrobic drug solutions serially diluted in Mueller-
Hinton broth to concentrations bridging the range of clini-
cal interest .. Panels of seven dilutions of each antimicro-
bic are provided in sequential wells of each plate, along 
with sterility and growth controls. The panels are frozen 
after preparation and are kept frozen at -20~C or lower 
until ready to be used. One panel is used for each test 
organism. The antibiotics included in the gram negative 
panel are the following: 
Antibiotic 
Ampicillin 
Cephalothin 
Gentamicin 
Tetracycline 
Carbenicillin 
Chloramphenicol 
Kanamycin 
Tobramycin 
Trimethoprim-Sulfa 
Nitrofurantoin 
Colistin 
mcg/ml ·Range 
16-0.25 
64-1.00 
16-0.25 
16-0.25 
512-8.00 
32-0.50 
64-1.00 
16-0.25 
32/608-0.50/9.50 
64 
4 
The MIC panels were inoculated and read as described 
in the manufacturer's instructions. The "turbidity standard 
technique" (47), whereby the bacterial suspension is brought 
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to the equivalent turbidity of a 0.5 HcFarland standard 
before dilution to the desired concentration was used to 
prepare the inoculum. Three to five isolated colonies from 
a Blood agar plate were inoculated into 2.5 ml of TSB and 
incubated at 35°C for 2-4 hours in order that the bacterial 
suspension could reach log-phase. This suspension was then 
diluted to an equivalent turbidity of the 0.5 McFarland 
standard. Five-tenth ml of the standardized suspension 
was pipetted into a tube containing 25 ml of sterile dis-
tilled water supplemented with 0.02% Tween 80. This 1:50 
dilution takes the bacterial suspension to approximately 
2 X l06CFU/ml. Five microliters of this inoculum was then 
transferred to each well in the microtiter plate using a 
special seeding plate thus making a further 1:20 dilution 
resulting in a final inoculum of 105 CFU/ml in each well. 
The plates were incubated for 15-18 hours at 35°C in an 
incubator under atmospheric conditions. The lowest concen-
tration (mcg/ml) of each antibiotic which demonstrated no 
visible growth was recorded as the minimum inhibitory con-
centration for the antibiotic,against each test organism. 
The single wells for nitrofurantoin (64 mcg/ml) and colistin 
(4.0,mcg/ml) were recorded for inhibition or resistance by 
each organism to these two antibiotics. 
The sterility and growth controls were checked before 
any test wells were even examined. Potency of the anti-
microbic dilutions and reproducibility of the technique 
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used were checked with each batch of MIG's run by testing 
control organisms with know MIG values. E. coli ATCC 
#25922 and P. aeruginosa ATCC #27853 were run with each 
batch of gram negative panels. Culture purity was checked 
by subculturing the final diluted inoculum (2 X 106 CFU/ml) 
onto a Blood agar plate. 
F. Preparation of Antigens for Immunization 
Each P. cepacia strain was inoculated onto Brain heart 
infusion agar plates (BHIA) and incubated at 35 C for 48 
hours. The bacteria were washed off the BHIA plates with 
10 ml of 0.5% Formalin and incubated at 35°C for 72 hours. 
The suspensions were utilized if plating a loopful of the 
bacteria-formalin mixture onto another BHIA plate and incu-
bating at 35°C for 48 hours resulted in no growth. 
Bacteria were washed five times with saline containing 
0.025% Formalin and 0.01% sodium azide. The bacterial sus-
pensions were adjusted in sterile saline to a density equi-
valent to that of a no.7 McFarland standard (approximately 
2.1 X 109 bacteria/ml) (53) and used for inoculations. 
G. Immtinization Procedure 
New Zealand white rabbits weighing 2-2.5 kg were inocu-
lated according to the following schedule; day 0, the rabbits 
were bled from the marginal ear vein for normal serum; day 1, 
0.25 ml of the cell suspension incorporated in 0.25 ml of 
Freund's complete adjuvant (Difco) was injected intradermally 
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and subcutaneously into several sites of the footpads and 
back; day 8, 0.1 ml of the cell suspension incorporated in 
0.1 ml of Freuna.~s complete adjuvant was injected intra-
muscularly into each thigh; and day 15, 1.0 ml of the cell 
suspension was injected intravenously into the marginal ear 
vein. The rabbits were bled on day 22 and every 2 to 3 
days thereafter for one week. The whole blood collected 
from the rabbits was allowed to stand at 25°C for approxi-
mately one hour, then overnight at 4°C. The clots were 
centrifuged at 2500 rpm several times to remove all blood 
cells from the sera. The sera collected each day from a 
rabbit were pooled and then quick-frozen in 1.0 ml aliquots 
and stored in a freezer at -ssoc. 
A total of 30 rabbits were immunized. The antisera 
were designated according to the antigen used for the immu-
nization of a rabbit. (eg. Anti-25416 was prepared by 
immunization of a rabbit with P. cepacia strain 25416.) 
Each anti.serum was tested against its respective anti-
', 
gen for the presence of antibody by slide agglutinationtesm 
using a saline suspension of each organism from a BHIA plate •. 
75-100% (3~4+} ~gglutination was obtained for each antisera. 
The following. gradations were used in scoring agglutination 
reactions; 1 + .(<25%) - questionable clumping, 2 + (SO%) -
definite clumping, supernate cloudy, 3 + (75%) - definite 
clumping, supernate clearing, and 4 + (100%) - completely 
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precipitated, supernate clear (27). A saline control was 
run with each organism to detect self-agglutinating strains. 
None of the P. cepacia strains were found to be self-agglu~ 
tinating. 
H. Preparation of Antigens for Tube Agglutination Studies 
Each P. cepacia strain was inoculated onto six Brain 
heart infusion agar plates and incubated at 35°C for 48 
hours. The bacteria were then washed off the BHIA plates 
with sterile saline. This bacterial suspension was then 
washed twice with saline. After the last centrifugation, 
the supernatant was decanted and the packed cells were re-
suspended in 10 ml of sterile saline and boiled for one 
hour. The heat-killed cells were washed again with sterile 
saline and finally resuspended in fresh saline to a density 
of a no. 3 McFarland standard, (approximately 9 X 108 bac-
teria/ml} (53). This type of suspension of P. cepacia was 
then used in the tube agglutination studies. 
I. Tube Agglutination Studies 
All twenty-nine antisera prepared against the P. 
cepacia strains and one antiserum prepared against P. fluo-
re:s·ce:ns 4f:l3525 were tested against each of the thirty-eight 
strains of P. cepacia and the P. fluorescens strain by 
doing tube agglutinations. Antiserum was prepared against 
the P. fluorescens reference strain to see if there would 
be any cross-reactivity between P. fluorescens and any of 
....-, 
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the P. cepacia strains since this organism is often confused 
biochemically with P. cep·acia. 
Serial dilutions of each antiserum tested were made 
in the following way: 0.9 ml of saline was pipetted into 
the first of ten 13 X 100 mm test tubes; the-following· 9 
tubes were filled with 0.5 ml of saline; 0.1 ml of the anti-
serum was placed into the first tube and mixed thoroughly; 
0.5 ml of the 1:10 dilution in the first tube wasttansferred 
to the second tube and so forth; thus a two~fold serial 
dilution was carried out to a final dilution of 1:5120 in 
the lOth tube. An additional tube with 0.5 ml of saline 
was set up for a saline control. Normal serum from each 
rabbit used for the immunizations was also diluted out 1:10 
and was used as a serum control. 
Each organism that vms used as an antigen was heat-
killed and a proper suspension prepared as described above. 
Five-tenth ml of the organism was then added to each serially . · 
diluted antiserum saline control and normal serum control 
tubes. The final dilutions in the tubes ranged from 1:20 
in the first to 1: 10, 240 -~ in the tenth tube. All the tubes 
were then incubated for 18 hours at 35°C and examined for 
macroagglutination (10). The endpoint titer was the highest 
dilution giving a 2 + .or greater agglutination reaction. 
, 
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Each of the described assays, whether biochemical, 
antibiotic susceptibility or serological, was performed at 
least twice for each of the 38 strains of P. · cepacia 
studied as well as for all of the control organisms. If a 
discrepancy in results occurred, the assay was repeated 
at least one more time and the result occurring most often 
was recorded. 
CHAPTER III 
RESULTS 
A. Biochemical Characteristics of the P.· cepacia Strains 
The thirty-eight strains of P. cepacia tested showed 
a high degree of similarity in their biochemical and cul-
tural characteristics based on 37 different tests using 
the conventional methods of King and others (37,58,74). 
Tables 1 and 2 summarize the results obtained when the 
two ATCC P. cepacia reference strains and the thirty-six 
clinical isolates of P. cepacia were tested. All 38 
strains of P. cepacia gave the following results: alkaline 
slant and butt in TSI with no H2S or gas production; oxida-
tion of dextrose, maltose, lactose, xylose, but not rham-
nose in OF media; positive mot~lity·; growth on MacConkey 
slants but no growth on SS agar; no denitrification of ni-
trate or nitrite to nitrogen gas; production of lipase but 
not DNAse, phenylalanine deaminase, indole or fluorescence; 
and utilization of citrate as a sole carbon source. Ninety-
seven percent (37/38) of the strains produced lysine decar-
boxylase and showed no hemolysis on sheep Blood agar plates 
(Table 2). One strain, K981, showed S-hemolysis on sheep 
Blood agar. Using the Sudan Black B stain, 95% (36/38) of 
the strains were found to accumulate PBHB inside their 
cells. Ninety-two percent (35/38) of the strains oxidized 
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Table 1. 
Biochemical.Propert~es of 38 Strains of P. ce~acia As 
Det:er.ni:lied W~th Conventicnal. Met:hods of 
·. · Icienti.f~c:.at~cn a, b • c 
-fai 
:z: :z: ~ e-. N ~ ~ ,..;:z:o :z: o 
,..; ,:.Ot-O::::l ~ :z: 
SntAINS 0 =~ O::::l ~~ :Z:ZOT 
- c.J - c.J 1:-o u ~ :;,. 0 ~ ,..; 1:;:;2 u 0 0 ~Q 
TESTED ~Q=~~:z:~~<~<~~~...;lt-ONOQ -,..;~,..;oo~Oc.J c.JOO::::lO~~:Z:O 
2075 -++-A++++++A++-+--+ 
2076 
2077 
B4134 -++-A++++-
2078 
2416 -++-A·+-
B4648 -++-A++++-+A+-
Kl021 -++-K.-+++++K+++-
D6460 -+-
Al'CC~0856 -++-A++++++A++-++ 
B-2 -++-A++++-
K808 -++-A+++-
!5910 -++-A++++++A++-+-+ 
2332 -++-A+++-++A++--
B6566 -++-A++++-
B5912 . 
2368 -++~A++++++A~+-+.+ 
23.69 . . . 
2331 - + +. A+++-
75-3351 -+·+-A++++-
1058 I -++-A++++++A-+--1059 
1060 -++-A++++++A--
75-2013 -++-A-+++-+A++-+---
LU3468 -++-A+++++-
Kl075 -++-K.+-++-+A-
Al'CC25416 -++-A++++++A+++ 
ll60 -++-A++++++A+-
CJ'62 I -++-A++-+-FB96 FB143 
K981 1+++-A+++-
2106 1-++-A+++++-A++-++ 
K998 -++-A++++-+A-
K.l036 -++-A++++-+A+++ 
LU2800 1 -++-A++++++A++--++ 
2371 I --++A+++++-K 
B-l -+-+A+-+++.;;;K-
a All 38 strains of P. cepacu gave the following 
react:~on for TSI: KK-- (slant/butt/gas/HzS) 
bAll 38 st::ains showed a positive reaction for the 
following 8 tests: CI'X,MOT,LIP,MAC SLAN"', OF DEX, 
OF MALX, OF LAC, OF XYL. 
cAll 38 strains were negative for the following 8 
tests: O'F CON, OF RliAM, DID, PHENYL,. SS, DNA.se, FLUOR, 
NO~z and N02~2· 
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Table 2. 
Summary of Biochemical Properties of 38 Strains of 
P. cepacia 
As Determined With Conventional Methods of Identification 
Substrate or character ffo of Strains (+)_ % of Strains (+) 
TSI 
Citrate 
Motility 
Lipase 
MacConkey agar slant 
OF Dextrose 
OF Maltose 
OF Lactose 
OF Xylose 
OF Control 
OF Rhanm.ose 
Indole 
Phenylalanine deaminase 
SS agar 
DNAse 
Auto-fluorescence (F/N) 
N03+N2. gas N02-+N2 gas 
Lysine decarboxylase 
PBHB 
OF Mannitol 
ONPG 
Esculin hydrolysis 
Oxidase 
Catalase 
Casein hydrolysis 
OF Sucrose 
Gelatinase 
Urease 
Yellow pigment 
Ornithine· decarboxylase 
MacConkey agar plate 
Growth at 420C 
N03-+N02 . 
Gluconate ·oxidation 
Lecithinase 
Hemolysis (B) 
38a 
38 
38 
38 
38 
38 
38 
38 
38 
0 
0 
0 
0 
0 
0 
0 
0 
0 
37 
36 
35 
35 
35 
35 
34 
34 
34 
32 
31 
27 
23 
21 
16 
14 
9 
2 
1 
100 
100 
100 
100 
100 
100 
100 
100 
100 
0 
0 
0 0 . 
0 
0 
0 
0 
0 
97 
95 
92 
92 
92 
92 
89 
89 
89 
84 
82 
71 
61 
55 
42 
37 
24 
5 
3 
aTSI reaction: alkaline slant, alkaline butt, no gas, no H2S. 
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When tested with the API 20E method, the P .. c·epa·cia 
strains showed a slightly greater degree of biochemical 
variability than was observed with the conventional methods. 
Tables 3 and 4 summarize these results. All the strains 
oxidized glucose and could utilize citrate as a sole carbon 
source but were negative for the following twelve tests; 
arginine dihydrolase, H2S, urease, tryptophan deaminase, 
indole, Voges-Proskauer, mannitol, inositol, sorbitol, rham-
nose, melibiose and nitrogen gas production. Ninety-five 
percent (36/38) of the strains produced S-galactosidase and 
Table 3. 
Biochemical Properties of 38 
Strains of P. cepacia As Determined With the 
API 20E Method a,b 
N 
0 
STRAINS C!) j:Q -~ p.. ~ u ~ ~ <'"I u u TESTED z t::a Q 0 ::::> Q 0 C!) ~ < z tf.l 0 
2077 + + + + + - + + 
2369 . 
2368 
2331 
2076 
2075 
2078 
2416 
2332 
K808 
B6566 + + + + + + 
LU2800 
K358 
K360 + + + + + + -
K359 
B5910 
B5912 
D6460 - + - + + -
K.l021 - + + - -
75-2013 + + + + + - + -
2106 
ATCC10856 
LU3468 + -
B4648 + - - -
B4134 
2160 + - + + -
ATCC25416 + + -
K981 + + + -
Kl075 
B-2 + + -
Kl036 
K998 + + + - - - -
CJ62 
FB96 
FB143 
B-1 + -
75-3351 + + + + + + 
2371 + - -
aAll 38 strains were positive for the follow-
ing reactions: GLU,CIT. 
bAll 38 strains were negative for the follow-
ing reactions: ADH,H2S,URE,TDA,IND,VP,MAN, 
INO,SOR,RHA,MEL, and N03~2 gas. 
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Table 4. 
Stmnary of Biochemical Properties of 38 Strains 
of P. cepacia As Determined 
With The API 20E System 
-
BioChemicals Tested a ffo of Strains (+) % of StrainS 
Arginine dihydrolase 0 0 
H2S production 0 0 
Urease 0 0 
Tryptophan deaminase 0 0 
Indole 0 0 
Voges-Proskauer 0 0 
Mannitol 0 0 
Inositol 0 0 
Sorbitol 0 0 
Rhannose 0 0 
Melibiose 0 0 
NOJ-+N2 gas 0 0 
Glucose 38 100 
Citrate 38 100 
ONPG 36 95 
Gelatinase 32 84 
Lysine decarboxylase 31 82 
Arabinose 26 68 
Amygdalin 26 68 
Sucrose 25 66 
Ornithine decarboxylase 19 50 
N03-+N02 9 24 
37 
(+) 
B.rhe following additional conventional tests, "WhiCh are not included 
in the API strip. are recomnend.ed by the manufacturers for use in 
the identification of the nonfermmters: OF-Qxidation, OF-Fermenta-
tion, Oxi.dase, Motility and Grcr..vth on Ma.cConkey agar. 
38 
84% (32/38) liquefied gelatin with the API method (_Table 4). 
Eighty-two percent (31/38) of the strains of l?. cepacia 
produced lysine decarboxylase on the API strip and 66% (_25/ 
38) of the strains oxidized the sucrose in the API micro-
tubes. Ornithine decarboxylase was detected in 50% of the 
38 strains and 24% (9/38) of the strains were shown to re-
duce nitrate to nitrite. The same number of strains (26/38) 
utilized amygdalin and arabinose in the API 20E system. 
These two tests were not included in the conventional system •. 
B. Biochemical Characteristics of Control Organisms 
Tables 5 and 6 summarize the results obtained with 
the eight control gram negative nonfermentative reference 
strains tested with the conventional King method and the 
API 20E method, respectively. The P. maltophilia, F. 
meningosepticum, P. aeruginosa, P. fluorescens, P. stutzeri 
and Achromobacter xyloseoxidans ATCC strains were correctly 
identified as such with the conventional method as well as 
with the API 20E system. The Acinetobacter calcoaceticus 
strain #23055 from ATCC was a poor grower. Although it 
could be identified using conventional media, it could not 
be properly identified using the API 20E system. The 
Xanthomonas campestris AT9C strain #6402 was identified 
with the conventional methods, while the API 20E system 
identified this organism as a CDC Group IIK-1. 
,.. 
' 
Table 5· 
aiochemical Properties of Control Organisms As 
Determined with. Conventional Methods of Identification 
STRAINS TES'l'ED 
<'a J Ol 
~ ~ I 
c 
I .-! " M :1)11'\ I II'\ Qjll'\ ~ ~ M c Ell'\ o..:r 0 CD II'\ CJN .loiN Substrate ·~ \0 -..4 ::IN Co-! CJ :::10 CQII'\ .j,,0 M c: CJ M -..40 .-! CJM G.IM CD< or 0 .-! QJ-..4 .-! .-! a!-..4 N !o<.-1 QJ\Q .j,, u e ~ u ::IU ·CJ .j,, u ou u Character .-! ~ u !o<U G.IU :::1 u eu :1 ~ . QJ ~ ., CO) £-1 . CJ£-1 .,.-~ ~ :<1·~ ~c. e f;r.. CD c.~< < <"a< c.. ow 
ISl a KK-b KK- KK- KK- KK- KK-
Urease + 
-
+ 
-
+ 
-
Indole ~ + 
- - - -Ci.trate + 
- + - + -
ONPG + + 
- - - -Oxidase 
-
+ + 
-
+ + 
catalase 3+c 3+ 3+ 1+ 2+ 3+ 
Lysine Decarb. + 
- - - - -
Orn:i.thine De-
carb. 
- - - - - -
PHENYL 
- - - - - -
Motility + -. + 
-
+ + 
PlmB . 
- - - - - -
NO;r+NQ2 + . - - - - -
DNAse + + 
- - -· -OF Dextrose A A A A A • A 
OF Maltose A A K A A A 
OF Sucrose 
-
K K K A A 
OF Lactose 
-
A K A K K 
OF Xylose K K A A A A 
OF Mal:mi.tol K A A K A 
-
OF Rhamnose K K 
-
A A 
-
OF Control K K K K K K 
Auto-Fluor. 
- -
+ 
-
+ 
-
N03~2 gas 
- -
+ 
- - -. 
NOrN2 gas - - + - - -
42°C BR.I/TSB 
-I- -I- +I+ -I- -I- -I-
Gluconate 
- - + - + -
Esculin + + - - - + 
Gelatin + + + + + -
Mac:Cbnkey pl I sl +I+ -I+ +I+ -I- +I+ -I-
Hemolysis (S) 
- -
+ 
- - -
Caseinase + + + - - -
Lipase + - + - - -
Lecithinase 
- -
+ 
- - -
Pigment 
- -
Green 
- -
Yellow 
Growth on ss 
- - + - + ~ 
aiSI react~on is read as follows: slant/butt/gas/H2S 
~-- • alkaline/alkaline/no gas/ no H2S 
CX) 
-..4 CX) 
$.111'\ 
Q,lf' 
No-! 
.j,,Cj 
:::1 u 
.,.j,, ~ ~ CD 
KK-
-
-
+ 
-
+ 
1+ 
-
-
+ 
+ 
-
. 
-
-
A 
A 
K 
K 
A 
A 
K 
K 
-
+ 
+ 
+I+ 
+ 
-
-
+I+ 
-
-
+ 
+ 
-
+ 
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.::. 
I< 
0 Qj 
.-! CD \0 
0 0 
'; " 
CDirJ I< . c:u
~ ~~ 
KK-
-
·-
+ 
-
+ 
3+ 
-
-
-
+ 
+ 
-
-
.:. 
K 
K 
K 
A 
K 
K 
K 
-
+ 
+ 
+I+ 
+ 
-
-
+I+ 
-
-
-
-
-
+ 
CThe folloving gradations were used for the catalase test: l+, weak or 
delayed bubble production; 2+, moderate bubble production; and 3+, 
vigorous bubble production (71). 
BIOCHEMICALS 
TESTED a 
Table 6. 
Biochemical Properties of Control Organisms As 
Determined With the API 20E System 
STRAINS TESTED 
I 
..-I CIS 9 til ..-I M CIS •r-1 ll'l ~ til r-1 (I) ll'l til ~ ll'l (I) •r-1 
•r-1 tllN 0 (I)O 0 J-1 •r-1 ~ ~ M ~ OM til ~ J-1 r-1 
-g If'\ CIIN (!)If'\ til (I)CX) 0 
"' 
~ u ..;r ou J.IN (I) N ~CX) ~ M •r-1 u ::I r-1 0 u 011'\ i 0 ~ ll'l r-1 \.0 ai ~ J.IO r-1 ~ ::1M ..;r ::lr--CISM (l)r-1 CIS r-1 r-1 \.0 ~ r-1 Sr-t a CISU 0 4-1 u ou tilt.) u u til u u u 
•U . . . ::I . E-4 . . 
I 
..-I 
~ 
0 (I) 
til 
0 
e ~ 
. 
0 p.. E-4 r:r..· ~I p.. ~ < 0 p.. < :<· ~ p..· ~ .< 
ONPG + + - - - + -
Arginine Dihy-
- - + - + - -drolase 
Lysine Decar-
+ - - - - - -boxy lase 
Ornitnini De-
- - - - - - -carboxylase 
Citrate + - + - + - -
HzS - - - - - - -
Urease - - + - - - -
TDA - - - - - - -
Indole - + - - - - -
Voges-Proskauer - - - - + - -
Gelatin + + + - - + -
Glucose - - + - - - -
Mannitol 
- - - - -
- -
Inositol 
- - - - - - -
Sorbitol - - - - - - -
Rhamnose - - - - - - -
Sucrose - - - - - - -
Melibiose - - - - - - -
Amygdalin - - - - - - -
Arabinose - - + - - - -
N03+N2 gas - - + - - - + 
NO~+ + - - - - - -
...-1 
\.0 
0 
"' N tilt.) 
~u 
~·~ 
-
-
-
-
-
+ 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+ 
-
aThe following additional conventional tests, which are not included 
on the API strip, are recommended by the manufacturers for use in 
the identification of the nonfermenters: OF-Oxidation, OF-Fermenta-
tion, Oxidase, Motility and Growth on MacConkey agar. 
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C. Antibiotic Susceptibility Patterns of the P. cepacia 
Strains 
The Kirby-Bauer antibiotic susceptibility results 
of the 38 P. cepacia strains showed the organisms to be 
very resistant, especially to the antibiotics commonly 
used for Pseudomonas infections, such as gentamicin, car-
benicillin, colistin, amikacin and tobramycin. Tables 7 
and 8 summarize these sensitivity patterns. All of the 
38 strains of P. cepacia tested were resistant to the 
following nine drugs: ampicillin, cephalothin, clindamycin, 
colistin, erythromycin, nitrofurantoin, oxacillin, peni-
cillin G and vancomycin. Ninety-seven percent (37/38) of 
the strains were resistant to gentamicin, tobramycin, tetra-
cycline and amikacin (Table 8). Ninety-five percent (36/ 
38) of the strains were resistant to carbenicillin; one 
strain showed an indeterminate zone size and one a sensi-
tive zone size. Eighty-two percent (31/38) were resistant 
to kanamycin; five strains had indeterminate zone sizes 
and two strains were sensitive. Eighty-seven percent (33/ 
38) were found to be resistant to ticarcillin; 3 strains 
showed indeterminate zone sizes and 2 strains were sensi-
tive. Forty-two percent (16/38) of the strains were re-
sistant, 3 strains were indeterminate and 19 strains were 
sensitive to nalidixic acid. Thirty-two percent (12/38) 
were resistant, 1 strain indeterminate and 25 strains (65%) 
Table 7. 42 
Antibiotic Susceptibility Testing Results on 38 Strains of P. ceoacia 
Using the Kirby-Bauer Method a 
"""' 
&t\ 
., 
·3 " r:: 
"'"' ~ . Q) 
"'"' 
CJ 
"'"' 
C""\ 
r:: r:: 
"""'-
< r:: 
"'"' 
N 
=- "'"'- - "'"'-
.-100 
-
....... Q)-
'"' --Strains ..-tOO .-100 00 .-100 """0 r:: 00 0 00 ...::oo C..CISilOOO CJ CJ CJ 0 r:: 0 .-f 0 o a """0 """0 Q..CJ 0 1.1-f u C) ~a >.a """a """a 
""" 
o e ~a a e .C.-fSS C) CJ CJ r::.o >- olol ::l 
Tested. CISO aso CISO l-ltn QJO eo "0 O· 1-10 QJC/.2&1'\ 1-1.-1 ~<"" ~.-f CIS I' .C.-f a:!C""\ """<"" OC""\ a N 
.c- o~o~- ..-~- CJ- ~-~- =- """'- .-f- "'"' 
. 
0 Q) ~ """ CIS CIS :· .c '"' .... ~ ~ ~ CJ ~ CJ ~ 
-
R R R R R R R R 
R R R R R R R. R s 
R R R R R R R R s 
R R R R R R R R s 
R R R R R R ·a R s 
R R R R R R R R s 
R R R R R R R R s 
R R R R R R R s s 
R R R R R R R s s 
R R R R R R R s s 
R R R R R R R s s 
R R R R R R R s s 
R R R R R R R s s 
R" R R R R R s R s 
R R R R R R I I s 
R R R R R R R s I s 
R R R R R R R s s s 
It R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R R s s s 
R R R R R R I s s s 
R R R R R R I s R s 
R R R R R R I s R s 
R R R R R R I s R s 
R R R R R R s s R s 
R R R R s R R R s s 
R R R R R s R R s s 
R R s R R R s R s s 
R R R R I R R s s s 
R R R R I R R s s s 
R R R R I R R s s s 
R R R R s I R s s s 
s s R s R R s s s s 
aAll 38 strains of P. cepacia were resistant to the following nine 
drugs: ampicillin, cephalothin, colistin, nitrofurantoin, vancoymcin, 
oxacillin, erythromycin, penicillin G, and clindamycin. 
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Table 8. 
Summary of Antibiotic Susceptibility Testing Results 
on 38 Strains of Pseudomonas cepacia 
Using the Kirby-Bauer Method 
Antimicrobial II of Strains II of Strains IJ of Strains %of Strains 
Tested Sensitive Indeterminate. Resistant Resistant 
.. 
Amp·icillin 0 0 38 100 
Cephalothin 0 0 38 100 
Colistin 0 0 38 100 
Nitrofurantoin 0 0 38 100 
Vancomycin 0 0 38 100 
Oxacillin 0 0 38 100 
Erythromycin 0 0 38 ~00 
Penicillin G 0 0 38 100 
Clindamycin 0 0 38 100 
Gentamicin l 0 37 97 
Tobramycin 1 0 37 97 
Tetracycline l 0 37 97 
Amikacin l 0 37 97 
Carbeni-cillin l l 36 95 
Ti-carcUlin 2 3 33 87 
Kanamycin 2 5 31 82 
Nalidixi-c Acid 19 3 16 42 
Chloramphenicol 25 1 12 32 
Trimethoprim- 37 0 l 3 
Sulfamethoxazole 
sensitive to chloramphenicol. Only one strain was found 
to be resistant to trimethoprim-sulfamethoxazole by this 
method. 
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The control organisms used with Kirby-Bauer anti-
biotic susceptibility testing, E. coli ATGG ffo25922, S. 
aureus ATGG ffo25923, and P. aerug'inosa ATGC ffo27853, were 
tested with each batch of susceptibilities run. Zone 
sizes in the acceptable range (45) were consistently 
achieved for the control organisms against the nineteen 
drugs tested with the P .. cepacia strains. 
The minimum inhibitory concentrations (MIG's) of 
nine drugs against the 38 strains of P. cepacia as deter-
mined by the Micro-Media microtiter antibiotic dilution 
method are listed in Tables 9 and 10. Data on the rela-
tionship between the MIG values obtained and Kirby-Bauer 
zones was taken from studies by Matsen and Barry (45). 
All 38 strains were found to have MIG's in the sensitive 
range (0.5-2/9.5-38 mcg/ml) to trimethoprim-sulfameth-
oxazole. All 38 strains tested against nitrofurantoin 
(at a concentration of 64 mcg/ml) and colistin (at a con-
centration of 4 mcg/ml) with this method were found to 
be resistant to both of these drugs. Most of the strains 
tested were also found to be resistant to ampicillin, ceph-
alothin, gentamicin, and tobramycin. Eighty-two percent 
(32/ 38) of the strains had MIG's ~ 16 mcg/ml for tetra-
Table 9. 45 
Minimum Inhibitory Concentrations 
of Selected Antibiotics for 38 Strains of P.cepacia 
STRAINS ANTIBIOTICS 
TESTED ~ 
Ul 
~ ~ (I) ~ r-1 8 z Q) ..0 1'<-1 t.) t.) z E-1 t.) t.) ::.0:: 
Kl021 <.5/9.5a >64 >4 >16 >64 ·16 8 >16 . 512 32 16 
D6460 <:.5/9.5 >64 >4 >16 >64 16 8 16 128 32 8 
K808 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 8 16 
B4134 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 8 16 
B-2 2/38 >64 >4 >16 >64 >16 >16 >16 256 8 32 
2076 .5/9.5 >64 >4 >16 >64 >16 >16 16 512 2 32 
Kl075 .5/9.5 >64 >4 >16 >64 >16 >16 >16 256 8 64 
K1036 .5/9.5 >64 >4 >16 >64 >16 >16 > 16 128 8 64 
B4648 1/19 >64 >4 >16 >64 >16 >16 >16 128 8 32 
2077 .5/9.5 >64 >4 >16 >64 >16 8 8 512 2 16 
2416 .5/9.5 >64 >4 >16 >64 >16 16 8 512 2 16 
2078 .5/9.5 >64 >4 >16 >64 16 16 8 512 2 16 
2075 .5/9.5 >64 >4 >16 >64 16 16 8 512 4 16 
K359 .5/9.5 >64 >4 >16 >64 0.5 . 0. 5 16 >512 32 <1 
2371 .5/9.5 >64 >4 8 32 16 16 1 >512 8 8 
K981 ~~5/9.5 >64 >4 >16 64 >16 >16 >16 >512 8 >64 
B-1 .• 5/9.5 >64 >4 >16 >64 >16 >16 4 64 8 64 
K358 1/19 >64 >4 >16 >64 >16 >16 >16 >512 16 >64 
2369 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 8 >64 
2368 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 8 >64 
75-3351 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 8 >64 
2332 1/19 >64 >4 >16 >64 >16 >16 >16 >512 8 >64 
2331 2/38 >64 >4 >16 >64 >16 >16 >16 >512 >32 >64 
K360 .5/9.5 >64 >4 >16 >64 >16 >16 >16 512 32 >64 
B6566 .5/9.5 >64 >4 >16 >64 >16 >16 >16 256 4 >64 
75-2013 ' 2/38 >64 >4 >16 >64 >16 16 >16 >512 16 16 
2160 2/38 >64 >4 >16 >64 >16 >16 >16 >512 32 16 
LU3468 1/19 >64 >4 >16 >64 >16 16 >1.6 >512 32 16 
CJ62 1/19 >64 >4 >16 >64 >16 16 >16 >512 16 32 
ATCC25416 1/19 >64 >4 >16 >64 >16 16 >16 >512 16 16 
2106 1/19 >64 >4 >16 >64 >16 16 >16 >512 16 16 
ATCC10856• .5/9.5 >64 >4 >16 >64 '.:.'i16 16 >16 >512 16 16 
B5910 .5/9.5 >64 >4 >16 >64 >16 >16 >16 512 8 64 
B5912 .5/9.5 >64 >4 >16 >64 >16 >16 >16 256 4 32 
FB96 .5/9.5 >64 >4 >16 >64 >16 16 >16 >512 8 16 
FB143 .5/9.5 >64 >4 >16 >64 >16 >16 >16 >512 32 32 
K998 1/19 > 64 >4 >16 >64 >16 > 16 >16 >512 16 32 
LU2800 .5/9.5 > 64 >4 >16 >64 >16 > 16 >16 >512 8 >64 
aA11 values reported are in mcg/ml. 
Table 10. 46 
Sunnnary of 
Microtit~r Antibiotic Dilution Susceptibility 
Testing Results on 38 Strains of Pseudomonas cepacia 
Drugs Tested MIC value Kirby-Bauer If of % of 
(mcg/ml) Breakpoints Strains Strains 
Colistin >4 Ra 38 100 
Nitrofurantoin >64 R 38 100 
Trimethoprim- 0.5-2/ s 38 100 
Sulfamethoxazole 9.5-38 
Ampicillin 8 s 1 3 
>16 R 37 97 
Cephalothin 32 R 1 3 
>64 R 37 97 
Gentamicin 0.5 s 1 3 
~16 R 37 97 
Tobramycin 0.5-4 s 1 3 
8 R 3 9 
~16 R 34 88 
Carbenicillin 64-128 s •4 12 
256 R 4 12 
~512 R 30 76 
Tetracycline 1-4 s 2 6 
8 I 4 12 
~16 R 32 82 
Kanamycin <1-8 s 3 9 
16 I 14 38 
32->64 R 21 53 
Chloramphenicol 2-8 s 23 61 
16 I 7 J..8 
?:32 R 8 21 
aS= Sensitive, I= Indeterminate, R= Resistant. 
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cycline; 12% were in the indeterminate range with 8 m~g/ml 
r (Table 10). Seventy-six percent (30/ 38) of the strains 
,. 
... 
showed MIG's ~ _512 mcg/ml, 4 strains showed MIG's of 
256 mcg/ml and 4 strains had MIC' s in the sensitive range 
forcarbenicillin. Only 21% of the strains had MIC's in 
the resistant range (~ 32 mcg/ml) for chloramphenicol; 18% 
. . 
had M IC' s in the indeterminate range and 61% (23/ 38} showed 
MIC' s in the sensitive range (2-8 mcg/ml). Fifty--: three 
percent (20/38) of the strains were found to be resistant 
to kanamycin; 38% had MIG's in the indeterminate ·range and 
3 strains were found to be sensitive to kanamycin. 
The control organisms, E. coli ATGG #25922 and 
P. a:ertiginosa ATGG 1!27853, were run with each batch of the 
iiiicrotiter MIG determinations, and gave minimum inhibitory 
concentratiqn values within plus or minus one well of the 
known values for these organisms (47). 
D. Tube Agglutination Studies 
The antisera prepared against the twenty-nine strains 
of P. cepacia and the control P. fluorescens- ATGC strain 
13525 were reacted in tube agglutination assays with each 
of the thirty-eight strains of P. cepacia and with the 
control P. fluorescens organism. The results are shown in 
Table 11 a,b,c. All of the strains were readily aggluti-
nated by the homologous antiserum. Homologous titers 
ranged from 80 to 2560. Titers obtained in reciprocal 
Table lla. 
Tube Agglutination Assay Titers of 29 
Antisera against P.cepacia and 38 P.cepacia Strains Used as Antigens 
ll-4 .:S 
00 
(\) ~ Antisera Against P. cepacia 
QOS::.-iO ~~~~~.-i 0 ~ co \0 Ln 
•.-lQ)"r'!tiJON \0 0'\ \0 M CO ~ I' M \0 I' .-i flo+Jw~o ~ Ln .-1 ,...... o \0 ..-.. o N ..-.. o ..-.. 
M ~1.2 £- ~ g cg Q ~ -;g ~ -;g ~ g ~ ~ g ~ 
IK1021 I IJ.280a 1280 - b - - - - - - - - - -
D6460 11.280 1280 - - - - - - - - - - -
~59 II - - 80 320 320 80 640 1280 80 320 320 80 -
2416 - - 320 640 640 640 320 1280 320 640 320 - 80 
B4134 - - 320 320 1280 320 1280 1280 160 640 320 80 160 
K808 - - 80 320 1280 1280 1280 640 160 320 16~ - 20 
B4648 - - 40 80 640 320 640 320 20 160 160 20 40 
2075 - - 80 320 640 320 320 640 80 160 320 80 40 
2078 - - 320 640 640 320 320 320 320 160 320 40 40 
2077 - - 640 2560 2560 1280 2560 2560 640 2560 1280 - 80 
K1036 - - - 40 320 320 320 40 1280 - - 1280 -
B-2 - - 640 1280 1280 1280 2560 2560 640 2560 1280 640 320 
2076 - - 640 1280 1280 640 1280 1280 320 640 1280 -' 160 
K1075 - - - 40 80 80 80 40 320 20 20 160 -
2371 - - - - 20 80 160 80 - 160 80 40 640 
K981 III - - - - - - - - - - - - 40 
B-1 IV - - - - - - - - - - - - -
B6566 V - 20 - - - - - 40 20 640 - - 20 
2331 - - - - - - - - - - - - -
K358 - - - - - - - - - 40 640 160 -
2369 - - - - - - - - - - 1280 640 -
2368 - - - - - - - - - - 2560 320 -
K360 - - - - - - - - - - 640 640 -
2332 - - - - - - - - - - - - -
175-3351 - - - - - - - - - - - - -
25416 VI - - - - - - - - - - - - -
10856 - - - - - - - - - - - - -
2160 - - - - - - - - - - - - -
175-2013 - - - - - - - - - - - - -
. LU346~ - - - - - - - - - - - - -
2106 - - - - - - - - - - - - -
CJ 62 - - - - - - - - 40 - - - -
B5910 VII - - - - - - - - - - - - -
- B5912 - - - - - - - - - - - - -
FB96 VIII 160 - - 80 - 160 80 80 - 80 160 - -
K998 80 - - 80 40 80 40 80 - 40 80 - -
FB143 320 - - 40 - 80 80 160 - - 80 - -
LU2800 40 80 20 - - 40 - - - ,_ 20 80 10 
. ~ighest serum dilution resulting in at least a 2+ (definite clumping, 
. supernate cloudy) agglutination. 
b(..:) = No agglutination 
Kl021 
D6460 
K359 
2416 
B4134 
K808 
B4648 
2075 
2078 
2077 
Kl036 
B-2 
2076 
K1075 
2371 
K981 
B-1 
B6566 
2331 
K358 
2369 
2368 
K360 
2332 
75-3351 
25416 
10856 
2160 
75-2013 
LU3468 
2106 
CJ62 
B5910 
B5912 
FB96 
K998 
FB143 
LU2800 
I 
II 
III 
IV 
v 
VI 
VII 
VIII 
Table llb. 
Tube Agglutination Assay Titers 
M 
00 
. 0'1 
::.:: 
b 
40 
80 
640 
40 
M 
I j:Q 
320 
320 
Antisera Against P.cepacia 
80 
2560 
640 
160 
160 
320 
80 
80 
40 
160 
80 
160 
80 
2560 
80 
20 
20 
20 
80 
320 
40 
640 
2560 
1280 
160 
M 
1.1') 
('f) 
('f) 
I 
1.1') 
...... 
160 
320 
80 
80 
~ighest serum dilution resulting in at least a 2+ agglutination. 
b(-) = No agglutination. 
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Table llc. 
Tube Agglutination Assay Titers 
Antisera Against P. cepacia 
ell en 
•.-1 p.. 
(J fJ) Q) ::1 
fJ) ell § .-1 0 M -~ 4-4 ~ ,.0 ~ .-1 00 0 ()() o.-100 '-'> '-'> 0 '-'> 0 0 
ell 0 (J o.-1 en o .-1 1.1"'1 0 N -::t N .-1 '-'> 00 
~ .1-J en ~ -::t 00 loO I M '-'> 0"1 0"1 N 
.1-J . !il ' 0 Q) 1.1"'1 0 .-1 1.1"'1 ::> ....., 1.1"'1 1=1:1 ::> Cf.l p.. P,.Cf.l N .-1 N ....... H (.) 1=1:1 ~ H 
Kl021 I·. b - - -- ,.. - - - -:· 
D6460 - - - - - - - - -
K359 II - - - - - - - .... -
2416 - - - - - - - - -
B4134 - - - - - - - - -
K808 - - - - - - - - -
B4648 - - - - - - - - -
2075 -
-
-
-
- - - - -
2078 - - - - - - - - -
2077 - - - - - - - - -
Kl036 
-
- - - - -
-
-
-
B-2 - - - - - - - - -
2076 - - - - - - - - -
Kl075 -. - - - - - - - -
2371 - 20a - - - - - - -
K981 III 
-
20 
- - - - - -
-
B-1 IV - - - - - - - - -
B6566 v 40 - - - - - - - -
2331 80 - - - - - - - -
K358 - - - - - - - - -
2369 - - - - - - - - -
2368 - - - - - - - - -
K360 -
-
- - -
40 - - -
2332 - - - - - - - - -
75-3351 - - - - - - - - -
25416 VI 1280 640 1280 640 1280 1280 - - -
10856 1280 1280 640 640 1280 1280 - - -
2160 1280 1280 12801280 1280 1280 - - -
75-2013 320 320 160 320 320 320 - - -
LU3468 80 640 640 320 640 640 - - -
210.6 320 320 640 160 320 640 - - -
CJ62 2560 1280 1280 640 1280 1280 - - -
B5910 VII - - - - - - 160 - -
B5912 - - - - - - 1280 20 -
FB96 VIII - - - - - - 160 320 40 
K998 40 80 - - - - 160 320 40 
FB143 80 80 - - - - 320 640 -
, LU2800 40 40 20 40 - - - 160 640 
~ighest serum dilution resulting in at least a 2+ agglutination. 
b(-) = No agglutination 
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tests for cross-reactivity were usually lower; however, a 
. . - . 
few strains were agglutinated in heterologous antisera. at 
the same or even higher titers than in homologous antisera 
(e.g. K359, 2416, Kl075, 2369). This phenOir~erion may be due 
to the variability of individual rabbits' abiliti.es to 
respond to various organisms as antigens. The antiserum 
prepared against the P. fluorescens reference strain reacted 
at a relatively low titer of 80 with its homologous antigen. 
This reference strain, in turn, only reacted with its own 
antiserum; there was no cross-reactivity found between any 
of the P. cepacia strains and the P. fluorescens reference 
strain. 
The results indicated that the P. cepacia strains 
vary in their antigenic markers, since no on~ antiserum 
agglutinated all of the organisms. Mor~over, patterns of 
reactivity were noted which appeared to distinguish 8 
groups as follows: Group I, consisting of strains Kl021 
and D6460; Group II, consisting of strains K359, 2416, 
B4134, K808, B4648, 2077, 2078, 2075, B-2, 2076, Kl036, 
K1075 and 2371; Group III, consisting o·f one strain~ K981; 
Group IV, also consisting on one strain, B-1; Group V1 
consisting of strains B6566, K358, 2368, K360, 2369t 2331, 
2332 and 75-3351; Group VI, consisting of strains 2160, 
75-2013, LU3468, 2106, CJ62 and ATCC strains 25416 and 
10856; Group VII, consisting of strains B5910 and B5912; 
and Group Vlll~ consisti.~g of the four remaini.~g strains 
FB96~ 1<998~ fB143 and LU2800. 
Each_ rabbit\s preimmunization serum was diluted 
1:10 and was used as a control against each P. cepacia 
strain and the ATCG P. fluorescens strain te-sted in the 
tube agglutination studies. The normal serum from the 
rabbit immunized with P. cepacia strain B6566 reacted at 
a dilution of 1:10 with strains (a) 2332, (b) D6460, 
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(c) Kl036, (d) 2371 and (e) P. fluorescens ATCC 13525. 
This titer was considered to be too low to interfere with 
any test agglutination titers since these titers were 
started at a 1:20 dilution. None of the remaining 29 
normal sera reacted with any of the strains tested. When 
incubated in a saline suspension, none of the 29 P.cepacia 
strains or the ATCG P. fluorescens strain were found to 
self-agglutinate. 
CHAPTER IV 
DISCUSSION 
With the marked increase in the isolation of gram 
negative. rods as a cause of nosocomial infections in hos-
pitals in recent years, the search for more rapid identi-
fication and characterization methods for these organisms 
has been extensive. Presently used conventional techniques 
involve assays for biochemical utilization of carbohydrates, 
amino acids, fatty acids, etc. in order to identify the 
nonfermenters. The necessity for standardization of pro-
duction, storage and use of the diverse media and of result 
interpretation makes these assays cumbersome to perform in 
the clinical microbiology laboratory. As an answer to this 
problem, several manufacturers have devised miniaturized, 
standardized, commercially prepared biochemical methods 
for the identification of gram negative bacilli (1). One 
such system, the API 20 Enteric strip, has been used 
successfully to identify members of the Enterobacteriaceae 
family. However, with the significant increase in isola-
tion from hospitalized patients and the hospital environ-
ment of other gram negative bacilli as those belonging to 
the Pseudomonadaceae and Achromobacteriaceae families, this 
system has also been applied to the identification of these 
53' 
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organisms. One purpose of this work was to compare conven-
tional biochemical methods and the API 20E system for the 
identification of Pseudomonas cepacia. 
The results for the 38 strains of P. ceEacia with con-
ventional media revealed certain nutritional ·characteris-
tics cotmnon to'all or most of the P. cepacia strains. These 
organisms oxidize a wide variety of carbohydrates in OF 
media, they are motile and they do not denitrify nitrate 
or nitrite to nitrogen gas. Most strains produce lipase 
and oxidase, hydrolyze casein and esculin and produce ~­
galactosidase and lysine decarboxylase, but not arginine 
dihydrolase or DNAse. Many strains produce a yellow pigment 
and accumulate poly-S-hydroxybutyrate in the cells, All of 
strains grow on MacConkey agar slants but not on SS agar. 
Our data based on 38 strains compares very closelywith 
that obtained by Gilardi (33). However, 97% of our strains 
produced lysine decarboxylase and 61% produced ornithine 
decarboxylase using the Key Scientific substrate tablets 
and ninhydrine reagent in chloroform (Table 2)$ while 
. I 
Gilardi reported 94% of the P. cepacia strains positive 
for lysine decarboxylase and only 47% for ornithine decar-
boxylase using Moeller Decarboxylase Base media. In our 
hands, this Moeller Decarboxylase medium was found to be 
unsatisfactory for the detection of lysine, ornithine or 
arginine decarboxylase activity from nonfermenters for the 
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following reasons: (a) The reaction in the medium is 
I 
based on a two step process (43), the first of which is 
glucose fermentation and nonfermenters will not ferment 
glucose; (b) the media is overlayed with paraffin or oil 
after inoculation and nonfermenters do not readily grow 
in an anaerobic environment; and (c) when growth of the 
organisms does occur, it takes several days to detect any 
change in the indicator system. In contrast, the Key 
Scientific method is simple to perform, does not require 
actual growth of the organism and results can be read in 
24 hours. Other minor discrepancies in biochemicalpatterns 
were noted. For example, 82% of our strains were positive 
for urease production but only 5% were positive for leci-
thinase production (Table 2), whereas Gilardi found that 
only 34% of his strains of P. cepacia produced urease and 
34% produced lecithinase. 
Using conventional methods, many different biochemical 
assays are required to differentiate these strains of ~ 
cepacia from other nonfermentative gram negative rods. 
Moreover, this method of identification was found to betime 
consuming and the assays difficult to standardize. Some of 
the assays required 48 to 72 hours of incubation. Results 
with this method were cumbersome to compile and many vari-
ables had to be considered to arrive at an identification. 
p 
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The API 20E method was easy to use and many of the 
nonfermentative gram negative rods could be identified in 
24 hours. The identification of less active nonfermenters 
required 48 hours and inoculation of four additional tests. 
One advantage of the API 20E identification system is that 
it is computer-based; that is, a computer is utilized to 
store and update data on biochemical variations of the 
different strains bei~g isolated, to sort the data and to 
come up with possible biochemical reaction combinations 
(profiles) which could identify a particular species. This 
"real time" information is available to the user of the 
system. The API system is capable of differentiating 
between even relatively inert strains of nonfermenters with 
the aid of the computer profile. 
Two organisms which P. cepacia is often confused with 
and misidentified as, using conventional methods, are Pseu-
domonas paucimobilis (King Group IIK-1) and Pseudomonas 
fluorescens. However, with the profile generated with just 
a few key positive reactions on the API strip, a differen-
tiation between these three strains can be made. P. fluo-
re.scens always shows negative reactions for lysine decar-
boxylase and amygdalin, whereas P. cepacia is always nega-
tive for arginine dihydrolase and the Voges-Proskauer reac-
tion. P. cepacia can be differentiated from P.paucimobilis 
(IIK-1), which is biochemically quite similar, on the basis 
of a "pattern" of biochemicals, which includes ·lysine 
decarboxylase, gelatin hydrolysis, and acid production 
from amygdalin, arabinose and glucose (1). 
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The conventional and the API 20E methods showed an 
overall 72% agreement on the 15 biochemicals comparatively 
tested with the 38 strains of P. cepacia. An examination 
of Tables 2 and 4 shows slightly higher percentages of 
positive reactions using the conventional method for the 
assays comparatively tested. For instance, 97% (37/38) of 
the strains of P. cepacia produced lysine decarboxylase 
with the Ninhydrine (Key Scientific) method, whereas only 
82% (31/38) of the strains were positive with the API 
method. Eighty-nine per cent of the strains oxidized 
sucrose in the OF media, whereas only 66% (25/38) of the 
strains oxidized the sucrose in the API microtubes. Nitrate 
reduction was shown in 37% of the strains with the conven-
tional method, whereas only 24% (9/38) of the strains were 
shown to reduce nitrate to nitrite with the API method. 
Eighty-four per cent (32/38) of the strains liquefied gela-
tin with the Key Scientific gelatin strips and 84% of 
the strains liquefied gelatin with the API method. How-
ever, there were ten strains which gave a positive result 
with one method and a negative result with the other method 
for this test. Therefore, it is felt that the sensitivity 
of the two methods is probably comparable and that neither 
58 
method is particularly sensitive in detecting strains pro-
ducing lesser amounts of gelatin hydrolase. Perhaps a 
longer incubation period (>24-48 hours) for this test would 
have shown a higher correlation of results for these ten 
strains. Ornithine decarboxylase was detected in 61% of 
the 38 strains with the conventional Ninhydrine method, 
but in only 50% of the strains withthe API method. The 
two methods were in agreement on 32 out of the 38 strains 
on this reaction and only one strain (LU2800) showed a 
positive reaction for ornithine decarboxylase with API and 
a negative reaction withthe conventional method. There 
were only a few other reactions in which a positive result 
was shown with API and a negative result with conventional 
media. One such exception was B-galactosidase: 35 out of 
38 strains produced B-galactosidase with conventional tube 
methods, whereas 36 out of 38 strains were positive with 
the API method. Only two biochemical assays, urease pro-
duction and mannitol oxidation, showed dramatically dif-
fering results between the two methods for the 38 strains 
of P. cepacia. Eighty-two percent of the strains produced 
urease and 92% oxidized OF Mannitol using conventional 
media, whereas none of the strains were positive for these 
two assays on the API strip. It was rioted that the pro-
duction of urease on the conventional urea agar slant was 
quite weak for the P. cepacia strains tested, and that the 
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amount of acid detectable in OF Mannitol for most P. 
cepacia was lesser than with most of the other sugars 
oxidized by the strains in OF media. Therefore, the API 
system must be less sensitive than conventional media in 
detecting weak reactions in these two assays. The urease 
reaction is not critical in the identification of P. 
cepacia strains when using conventional methods; however, 
the OF Mannitol reaction is of importance in differentia-
ting P. cepacia from King Group IlK organisms. Therefore, 
a positive reaction in mannitol on the API strip could be 
helpful in differentiating P. cepacia strains from other 
nonfermentative gram negative rods. Even though this 
slight variability in percentages of positive reactions was 
found between the two methods, it is the overall pattern 
of reactions that is important in arriving at an identifi-
cation with the API system. Therefore, a 100% agreement 
was found between the two methods on the final identifica-
tion of the 38 strains of P. cepacia. 
In general, the API 20E system was found to be easy, 
rapid and convenient to use. The 22 biochemicals which 
are read directly from the API strip can easily be uniform-
ly inoculated in a minimal amount of time and then easily 
be read. The highly satisfactory agreement between results 
from the API system when compared with conventional methods. 
definitely shows the API 20E system to be very useful in 
the rapid identification of P. cepacia and probably most 
gram negative nonfermentative rods. 
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The control ATCC strains of P. ma:ltophilia, P. aerugi-
nosa, P. stutzeri, F. meningosepticum, P. fluorescens and 
Ac. xyloseoxidans were readily identified with both bio-
chemical systems. X~ campestris does not appear in the 
Weaver scheme but the organism can be identified using con-
ventional methodology and interpreting the results with 
the aid of Bergey's Manual. The API 20E profile also does 
not provide for the identification of Xanthmnonas so ATCC 
6402 was identified as a IIK-1. The Acinetobacter calcoace-
ticus ATCC strain grew poorly, and was eventually properly 
identified using conventional methods, but could not be 
identified on the API 20E strip. 
The biochemical patterns of the P. cepacia strains 
were analyzed to determine whether there might be clusters 
of organisms showing similar reactions. Three biochemical 
characteristics appeared to be useful in this regard: (a) 
the ability to oxidize sucrose, (b) the ability to produce 
ornithine decarboxylase and (c) the ability to reduce 
nitrates to nitrites. The reactions of the five biogroups 
obtained are shown in Table 12. When other selected bio-
chemical characteristics, including pigment production, 
gluconate and OF mannitol oxidation, and urease, casein 
hydrolase, B-galactosidase and lecithinase production, were 
Table 12. 61 
Biogroupings of the 38 Strains of P. cepacia 
Based on Sucrose Oxidation, Nitrate 
Reduction and Ornithine Decarboxylase Production 
Strains of Sucrose Nitrate Ornithine 
Biogroup P. ceEacia Oxidation Reduction Decarboxylase 
1 Kl021 - - + 
D6460 
2 2075 + 
2076 
2077 
B4134 
2078 
2416 
B4648 
B-2 
K808 
3 B5910 + + 
B5912 
2332 
B6566 
2368 
2369 
2331 
75-3351 
K358 
K359 
K360 
LU2800 
4 Kl075 + - -
Kl036 
K981 
., 75-2013 
LU3468 
10856(ATCC) 
25416(ATCC) 
2160 
CJ62 
2106 
FB143 
K998 
FB96 
5 2371 - + 
B-1 
r 
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compared for the five biogroups (Table 13), Biogroups 1, 2, 
3, and 5 seemed to be quite homogenous, whereas the 13 
strains assigned to Biogroup 4 showed many variable reac-
tions. Thus, additional biochemical tests may be needed 
to differentiate additional subgroups among these Biogroup 
4 strains. 
Antibiograms have been recognized not only as epidemio-
logical tools in tracing outbreaks or patterns of organism 
isolation in hospitals (6, 19) but also as a diagnostic aid 
in the identification of organisms (31). The antibiotic 
susceptibility testing of the thirty-eight P. cepacia 
strains revealed a characteristic sensitivity pattern for 
this organism which is quite distinctive from that of most 
of the other Pseudomonas sp. Most of the strains of P. 
cepacia were found to be resistant to tetracycline,colistin. 
tobramycin, gentamicin, carbenicillin, amikacin and ticar-
cillin. In contrast, P. fluorescens is usually resistant 
to carbenicillin, gentamicin and tetracycline (33), but 
only P. cepacia consistently shows a combined resistance to 
tobramycin, colistin and amikacin in addition to these 
three drugs. Therefore, the antibiotic sensitivity pattern 
is definitely helpful in the differentiation of P. cepacia 
from other Pseudomonas sp. 
Since organisms being isolated from hospitalized 
patients today are becoming increasingly resistant to the 
63 
Table 13. 
Analysis of the Five Biogroups of P. cepacia 
Based on Seven 
Additional Biochemical Characteristics 
Biogroups 
Characteristic 1 2 3 '4 5 
Yellow pigment a +b variable c + - -
··Gluconate oxidation + - - variable -
Urease + + + variable + 
Casein hydrolysis + + + variable -
ONPG - + + variable + 
OF Mannitol K A A variable A 
Lecithinase - - - - + 
a(-) = At least 90% of the members of named Biogroup showed a 
negative reaction. 
b(+) = At least 90% of the memb~rs of named Biogroup showed a 
positive reaction. 
cvariable =Named Biogroup's members did not show the same reaction 
for this assay. 
---
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antibiotics currently available for treatment, there has 
been an increasing demand on the clinical microbiology lab 
from physicians for determining minimum inhibitory concen-
trations of antibiotics against a clinical isolate. The 
method chosen to determine the MIC's for the 38 strains of 
P. cepacia was a microtiter technique (MicXO...,Media Systems, 
Inc.) in which the antibiotics are prepared and frozen in 
microtiter plates. This method is standardized,FDA approved, 
simple to perform, easy to read and to interpret results. 
The only drawback of the method is its expense, yet this is 
partly compensated by a savings of technician time. 
A compar'ison of the antibiotic susceptibility patterns 
determined for the 38 strains of P. cepacia with the Kirby-
Bauer (Table 7) and the MIC (Table 9) methods revealed a 
high degree of agreement for most of the antibiotics 
studied. There was complete agreement of results between 
the two methods 92.5% of the time. Twenty-five antibiotic-
organism combinations showed an indeterminate value v7ith 
the MIC method and either sensitivity or resistance with 
the Kirby-Bauer method. Generally, this is considered as 
acceptable agreement (29). Definite differences in results 
were seen in only six instances, where strain 2331 for TM-
SXT, strain B-1 for tetracycline, strain 2371 for ampicillin 
and strains Kl036 and D6460 for carbenicillin showed resis-
tance with Kirby-Bauer and sensitivity with the MIC method, 
65 
and where strain K359 showed resistant MIC values for 
chloramphenicol but was found to be sensitive with the 
Kirby-Bauer method (Tables 7 and 9). In these cases, the 
MIC result may be considered more accurate than the Kirby-
Bauer result (38). If one also considers the level of anti-
biotics, which can be achieved in the blood using different 
routes of drug administration (38). the benefits of MIG 
determinations are evident. For instance, five strains 
(75-2013, CJ62, ATGG25416, 2106, ATCG10856)which showed 
MIG's of 16 mcg/ml for chloramphenicol(Table 7) were inter-
preted as having resistant zones with the Kirby-Bauer method 
(Table 9). However, if chloramphenicol were administered 
intravenously (1 gm, q6h), 20 to 30 mcg/ml levels of this 
drug could be reached in the blood; therefore, chlorampheni-
col may still be an effective drug against those strains of 
P. cepacia. 
Even though P. cepacia strains are resistant to colis~ 
tin, Rahal (60) has reported that the combination of this 
i drug with trimethoprim-sulfamethoxazole, to which most P. 
cepacia strains are very sensitive, is synergistic, bac-
tericidal and more effective than trimethoprim-sulfamethoxa-
zole alone against P. cepacia infections. Although possible 
synergism between drugs can sometimes be shown using the 
Kirby-Bauer method (60, 67), performing checkerboard MIG's 
would be very useful in determining exactly what achievable 
---
levels of these two antibiotics would show most. synergism 
against a particular strain. 
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Eight serogroups were distinguished from the 38 strains 
of P. cepacia serologically tested on the basis of the 
cross-reactivity seen between these strains in agglutina-
tion studies with the prepared antisera. The reactions 
observed were probably due to agglutinins formed against 
thermostable 0 antigens, since the thermolabile H antigens 
would be de~troyed by ·the boiling used in preparing the 
antigens. However, the possibility that some of these reac-
tions were associated with either heat stable components, 
possibly even "core" polysaccharide, can not be ruled out 
(13). To determine whether there are true antigenic simi-
larities between the strains that seem to fall into similar 
serogroups, adsorption studies of the appropriate antisera 
with the cross-reacting antigens would have to be carried 
out. 
The eight possible groups proposed for the P. cepaci~ 
strains show some cross-reactivity between the groups. For 
example, strains K1036, Kl075 and 2371 of Group II aggluti-
nated with antisera to antigens belonging to Group II and 
to the antiserum to R981 in Group III (Table 11 a, b). 
Strains K358, 2369, 2368 and K360 from Group V agglutinated 
with antisera belonging to Group V but also with antisera 
against strains 2076 and Kl075 which were assigned to Group 
II. An unusual nonreciprocal cross-reactivity pattern was 
r 
observed between strain B-1, belonging to Group· IV and 
strain 2371 of Group II. Anti-B-1 reacted with B-1 and 
2371 at a titer of 320; however, anti-2371 only reacted 
with 2371 and other strains in Group II (Table 11 a, b). 
Dudman (21) observed a similar occurrence between strains 
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of Rhizobium japonicum and suggested that either cross-
reacting antibodies were involved, or the antigenic deter-
minants were present but only in limited amounts. There-
fore, a similar phenomenon may be involved with these two 
strains of P. cepa·cia, but cross-adsorption studies would 
be necessary to clarify these points. Strains FB96, R998, 
FB143 and LU2800 assigned to Group VIII differed from all 
the other strains in that these strains as a group cross-
reacted with 19 out of the 29 antisera prepared against 
the P. cepacia strains, even though their antisera only 
reacted wi.th the four members of their group (Table 11 a, b, 
c). Cross-reactivity with the unadsorbed antisera prepared 
for typing 0 antigens of P. aeruginosa has also been: reported· 
to be a problem (22). Duncan, et al (22) were able to abo-
lish cross-reactivity in the typing antisera without signi-
ficantly reducing titers against the homologous strains in 
two ways, either by adsorbing with the specific 0 antigens 
cross-reacting or by adsorbing the antisera with a poly-
agglutinable strain. Therefore, the preparation of fully 
specific, non-cross-group-reacting antisera for the· P. 
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cepacia groups may also be possible by either of these 
methods. The antiserum showing highest reactivity in each 
group would be adsorbed with cross-reacting antigens outside 
of the group or possibly with a poly-agglutinable strain as 
one of those in Group VIII to prepare antisera specific for 
members of its group. 
The results of the biochemical reactions and antibio-
tic susceptibility and serological studies of these 38 
strains of P. cepacia confirm previous observations that 
strains of P. cepacia share many distinct characteristics, 
yet the species is not very homogenous internally (49). 
Since distinct biochemical, antibiogram and tube agglutina-
tion patterns were observed, an attempt was made to see if 
the members of the eight serological groups also shared 
similar biochemical and antibiotic susceptibility character-
istics. 
Strains Kl021 and D6460 which comprise serological 
Group I were found to be biochemically identical and unique. 
They produced ornithine decarboxylase but did not oxidize 
sucrose or reduce nitrate. They also oxidized gluconate 
but did not oxidize mannitol, produce a-galactosidase or 
form a yellow pigment (Tables 12 and 13). The MIC values 
showed that both strains are resistant to chloramphenicol. 
show indeterminate values to kanamycin and moderately resis-
tant valuesfor tobramycin (Tables 9 and 10). 
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The nine out of 13 members of serological Group II 
(that is, organisms 2077, 2076, 2416, K808, B4648, B4134, 
B-2, 2075 and 2078) (Table lla) which were found to react 
most closely serologically were also found to have virtually 
identical biochemical reactions (Tables 12 and 13). These 
nine strains all produced ornithine decarboxylase, oxidized 
sucrose, produced a yellow pigment, hydrolyzed gelatin 
(Table 1) and did not reduce nitrate. The other 'four mem-
bers of Group II showed quite variable biochemical reactions~ 
Strains Kl036 and Kl075 did not produce ornithine decarboxy-
lase nor reduce nitrate but they did oxidize sucrose (Table 
12). K359 was positive for all three of-these reactions. 
Strain 2371 reduced nitrate but did not produce ornithine 
decarboxylase or oxidize sucrose. The antibiograms of the 
organisms in this group were quite similar. Eleven out of 
the 13 strains had comparable MIG values against the nine 
antibiotics titered. All eleven of these strains showed 
low MJC values to chloramphenicol and intermediate or mod-
erately resistant values to kanamycin (Table 9). Nine out 
of the 11 strains had resistant MIG values to carbenicillin 
--strains K1036 and B4648 were found to be sensitive. Seven 
out of these 11 strains had resistant MIG values to tetra-
cycline--strains 2077, 2416, 2078 and 2075 showed inter-
mediate values. The two rema~ing strains K359 and 2371, 
both showed much more sensitive drug susceptibility patterns 
(Table 9). 
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Strain K981, was serologically distinct anQ., therefore, 
was designated Group III. This organism was unique since 
it was the only one o.f th.e 38 P. cepacia strains tested 
which produced ~-hemolysis on a Blood agar plate (Table 1). 
1<981 was found to have similar MIC values to Kl.036 and Kl075 
of Group I I in that they were only sensitive to chloramphe-, 
nicol, trimethoprim-sulfamethoxazole and nalidixic acid 
(Table 7). The antiserum prepared against 1<981 also reacted 
with strains Kl.036 and Kl075. Moreover, it was found that 
K981 biochemically resembles Kl036 and Kl075 in that all 
three strains oxidized sucrose but did not produce ornithine 
decarboxylase or reduce nitrate (Table 12). 
Group IV, which consists of one member, B-1, appears 
to be distinguishable from most P. cepacia strains in that 
the MIC values showed it to be sensitive to tetracycline 
and carbenicillin (Table 9). However, B-1 does biochemi-
cally resemble organism 2371 of Group II. Both of these 
strains did not produce ornithine decarboxylase or oxidize 
sucrose but did reduce nitrate to nitrite (Table 12). 
These two strains are also similar to each other and dif-
ferent from other P. cepacia strains in that they did not 
produce a yellow pigment, hydrolyze casein but did produce 
lecithinase (Table 13). The~wo strains do not, however, 
have similar antibiograms. / 
The eight strains in Group V (Table 11 b) are biochemi.'"" 
cally very closely related and quite representative of a 
/ 
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"typical" P. cepacia strain. All 8 strains produced orni-
thine decarboxylase, oxidized sucrose and reduced nitrate 
to nitrite (Table 12). All 8 strains had very high MIG's 
(>64 mcg/ml) to kanamycin (Table 9). Seven of the 8 strains 
also showed very high MIG values to carbenicillin and were 
resistant to nalidixic acid (Table 7). Six of the 8 strains 
were sensitive to chloramphenicol. 
Group VI, which is comprised of seven serologically 
closely related strains (Table llc), was found to be quite 
homogenous in biochemical characteristics and antibiotic 
susceptibilities. All eight strains oxidized sucrose but 
did not produce ornithine decarboxylase or reduce nitrate. 
All the strains produced a yellow pigment and hydrolyzed 
esculin. Seven of the 8 strains hydrolyzed gelatin and 
casein (Tables 1, 12 and 13). This group of strains differed 
from most other strains of P. cepacia in that their MIG 
values for chloramphenicol were either intermediate or re-
sistant. These 9 strains also showed very high MIG's (>512 
mcg/ml) for carbenicillin but intermediate values for kana-
mycin (Table 9). 
Strains BS910 and B5912, which are included in Group 
VII, are almost identical in their biochemical characteris-
tics and are very similar in their drug sensitivities. Both 
strains produced ornithine decarboxylase, oxidized sucrose 
and reduced nitrate to nitrite (Table 12). Both strains 
were found to be resistant to all of the drugs tested except 
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chloramphenicol, trimethoprim-sulfamethoxazole and nalidixic 
acid (Table 7). They differed only in that B5910 produced 
a yellow pigment and B5912 did not, on all media on which 
the two strains were grown. 
Strains FB96, FB143, K998 and LU2800 were all assigned 
to a single serological group (VIII) because of serological 
relatedness. Biochemically, the first three strains were 
also found to be quite similar. All three oxidized sucrose 
but did not .produce ornithine decarboxylase or reduce nitrate 
(Table 12}. Strain LU2800 was positive for all three of 
these reacti.ons. All four strains had similar antimicrobial 
susceptibility patterns, showing very high MIC values to 
tetracycline and carbenicillin and resistance to kanamycin 
and nalidixic acid (Tables 7, 9). All of the strains except 
FB143 were found to be sensitive to chloramphenicol. 
Thus, analysis of the biochemical, antibiotic suscepti-
bility and serological properties of the P. cepacia strains 
indicates that differences in serological reactivity can 
be correlated with differences in antibiograms and biochemi-
cal reaction patterns. Therefore, it seems plausible that 
a simple agglutination procedure exists which permits the 
rapid presumptive identification and determination of the 
antibiograms of P. cepacia strains isolated from clinical 
specimens. Further studies of new isolates are required to 
confirm the full feasibility of this approach. 
--
SUMMARY 
A detailed analysis of the biochemical, antibiotic 
susceptibility and serological characteristics of 38 dif-
ferent clinical isolates of P. cepacia was conducted. Con-
ventional methods for biochemical assays, described by 
Weaver, Gilardi and Pickett, and the API 20E Identification 
System were comparatively studied for their use in the 
identification of P. cepacia strains. Antimicrobial sus~ 
ceptibility patterns of P. cepacia were studied using the 
Kirby-Bauer single disk diffusion method and the Micro-
Media Microtiter method. Serological reactivity of the 
38 strains of P. cepacia was examined by preparing antisera 
against 29 strains of P. cepacia and testing the antisera 
against heat-killed antigens of P. cepacia by performing 
tube agglutinations. An attempt was then made to correlate 
the differences in serological reactivity with differences 
in antibiotic susceptibility and biochemical reaction pat-
terns determined for the diverse strains of P. cepacia. 
Conventional methods of identification of nonfermenta-
tive gram negative bacilli based on physiological charac-
teristics were used to differentiate the P. cepacia strains 
from the other nonfermentative rods. These assays were 
found to be time-consuming and difficult to standardize. 
Results were cumbersome to compile and many variables had to 
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be considered to arrive at an identification of the strains. 
The API 20E strip was found to be easy to use, could be 
uniformly inoculated and identifications could be made in 
24-48 hours. Some variabilities in the biochemical assay 
reactions were found between the two methods~ However, 100% 
agreement was reached on the final identification of the 
38 strains of P. cepacia. This highly satisfactory agree-
ment between the API system when compared with the conven-
tional methods and the rapidity and ease of identification 
with the API ·system definitely shows the API 20E system to 
be very useful in the rapid identification of P. cepacia. 
Antibiotic susceptibility testing with the Eirby-Bauer 
and the MIC methods of the· P. cepacia strains showed that· 
most P. cepacia strains exhibit a combined resistance to 
tobramycin, colistin, amikacin, carbenicillin, gentamicin 
and tetracycline, a characteristic which distinguishes _ 
them from the other Pseudomonas· ·sp. Therefore, antimicro-
bial susceptibility testing was found to be helpful in the 
differentiation of p·. cepacia from other Pseudomonas sp. 
The MIC Microtiter system was studied with the 38 strains 
of P. cepacia in search for an alternative to the Kirby-
Bauer method and for a more accurate system for drug suscep-
tibility testing. The Micro-~1edia MIC determination method 
was found to be a highly standardized method which is simple 
to use and easy to read and interpret results. A high 
degree of correlation was found between the MIC values and 
75 
the. Kirby-Bauer method results for the eleven drugs com-
paratively tested. The determination of MIC values is 
thought to be beneficial in the treatment of highly-resis-
tant organisms, such as Pseudomonas cepacia, because the 
numerical drug susceptibility results can better be cor-
related with achievable blood levels and different routes 
of drug administration. 
With the growing need to detect and document the spread 
of specific strains of organisms through hospitals, a sero-
logical analysis of P. cepacia was begun. Eight possible 
serogroups were determined from the 38 P. cepacia strains 
tested, based on the cross-reactivity seen between these 
strains in tube agglutination studies with unadsorbed anti-
sera. True anti.genic similarities between the strains can-
not be determined at this point without adsorption studies 
of the appropriate antisera with cross-reacting antigens. 
An analysis of the biochemical, antibiotic susceptibi-
lity and serological patterns of the P. cepacia strains 
indicates that differences in serological reactivity can be 
correlated wi.th. differences in antibiograms and biochemical 
reaction patterns. Thus, it may be possible to develop sero;.. · 
typing anti.sera which could be used as a diagnostic as well 
as epidemiological tool, permiting the rapid presumptive 
identification and determination of the antibiograms of 
· P. cepacia strains isolated from clinical specimens. 
REFERENCES 
1. Analytab Products. 1977. API 20E Analytical Profile 
Index. Analytab Products, Inc. Plainview, N.Y. 
2. Ballard, R. W., N. J. Palleroni, M. Doudoroff, R. Y. 
Stanier, and M. Mandel. 1970. Taxonomy of the 
aer9bic pseudomonads :. Pseudomonas cepacia, 
P. marginata, P. a11iicola and P. caryophylli: 
J. Gen. Microbiol. 60:199-214. 
3. Bassett, D. C., K. J. Stokes, and W. R. G. Thomas. 
1970. Wound infection with Pseudomonas multivorans. 
· A water-borne contaminant of a disinfectant solu-
tion; Lancet 1:1188-1191. 
4. Bassett, D. C. J., J. A. S. Dickson, and G. H. Hunt. 
1973. Infection of Holter valve by Pseudomonas-
contaminated chlorhexidine. Lancet 1:1263-1264. 
5. Bauer, A. W., W. M. Kirby, J. C. Sherris, and M. Turck. 
1966. Antibiotic susceptibility testing by a stan-
dardized single disk method. Am. J. Clin. Pathol. 
45:493-496. 
6. Bobo, R. A., E. J. Newton, L. F. Jones, L. H. Farmer, 
and J. J. Farmer III. 1973. Nursery outbreak of 
Pseudomonas aeruginosa: epidemiological conclusions 
from five different typing methods. Appl. Microbiol. 
25:414-420. 
7. Burdon, K. L. 1946. Fatty material in bacteria and 
fungi revealed by staining dried, fixed slide pre-
parations. J. Bacteriol. 52:665-6 78. 
8. Burkholder, W. H. 1950. Sour skin, a bacterial rot of 
onion bulbs. Phytopathol. 40:115-117. 
9. Cabrera, H. A., and M. A. Drake. 1975. An epidemic 
in a coronary care unit caused by Pseudomonas species. 
Am. J. Clin. Pathol. 64:700-704. 
10. Campbell, D. H., J. S. Garvey, N. E. Cremer, and 
D. H. Sussdorf. 1970. Methods in immunology, 2nd 
ed. W. A. Benjamin, Inc., New York, N.Y. 
76 
77 
11. Carson, L. A., M. S. Favero, W. W. Bond, and N. J. 
Petersen. 1973. Morphological, biochemical and growth 
characteristics of Pseudomonas cepacia from distilled 
water. Appl. Microbiol. 25:476-483. 
12. Carson, L. A., and N. J. Petersen. 1975. Photoreacti-
vation of Pseudomonas cepacia after ultraviolet 
exposure; a potential source of contamination in 
ultraviolet-treated waters. J. Clin. Microbiol. 
4:462-464. 
13. Chester, I. R., P.M. Meadow, and T. L. Pitt. 1973. 
The relationship between the a-antigenic lipopoly-
saccharides and serological specificity in strains of 
P. aeruginosa of different 0-serotypes. J. Gen. 
Microbial. 78:305-318. 
14. Christensen, W. B. 1946. Urea decomposition as a means 
of differentiating Proteus and paracolon cultures 
from each other and from Salmonella and Shigella 
types. J. Bacterial. 52:461-466. 
15. Close, J., and P. A. Nielsen. 1976. Resistance of a 
strain of Pseudomonas cetacia to esters of p-
hydroxybenzoic acid. App . Environ. Microbiol. 31: 
718-722. --
16. Cooper, R. M., R. P. Leach, and R. C. Noble. 1976. 
Pseudomonas endocarditis in a heroin addict. J. 
KentuckyMed. Assoc. 74:135-139. 
17. Dailey, R. H., and E. J. Benner. Necrotizing pneu-
monitis due to the pseudomonad "eugonic oxidizer 
group 1". New Engl. J. Med. 279:361-362. 
18. Darby, C. P. 1976. Treating Pseudomonas cepacia 
meningitis with trimethoprim-sulfamethoxazole. Am. 
J .. Dis. Child. 130:1365-1366. 
19. Dayton, S. L., D. Blasi, D. Chipps, and R. F. Smith. 
1974. Epidemiological tracing of Pseudomonas aerugi-
nosa: antibiogram and serotyping. Appl. Microbial. 
27:1167-1169. 
20. Doudoroff, M., and N. J. Palleroni. 1976. Genus I. 
Pseudomonas, p.227-230. In R. E. Buchanan, N. E. 
Gibbons (ed.), Bergey's manual of determinative 
bacteriology, 8th ed. Williams and Wilkins, Co., 
Baltimore, Md. 
21. Dudman, W. F. 1971. Antigenic analysis of Rhizobium 
japonic·um by immunodi.ffusion. Appl. Microhiol. 21: 
973-985. . -
"78 
22. Duncan, N. H., N. A. Hinton, J. L. Penner, and I. B. R. 
Duncan. 1976. Preparation of typing antisera specific 
for 0 antigens of Pseudomonas aeruginosa. J. Clin. 
Microbial. 4:124-128. 
23. Ederer, G. M. , and J. M. Matsen. 1972. Colonization and 
infection with Pseudomonas cepacia. J. Infect. Dis. 
125:613-618. 
24. Ewing, W. H. 1972. Media and reagents, p.337-356. In 
P. R. Edwards and W. H. Ewing (ed.), Identification 
of Enterobacteriaceae, 3rd ed. Burgess Publishing 
Co., Minneapolis, Minn. · 
25. Ewing, W. H., and W. J. Martin. 1974. Enterobacte.riaceae, 
p.l89-221. In E. H. Lennett, E. H. Spaulding, and J.P; 
Truant (ed.~ Manual of clinical microbiology, 2nd ed. 
American Society for Microbiology, Washington, D.C. 
26. Farmer III, J. J. 1976. Pseudomonas in the hospital. 
Hosp. Prac. 11:63-70. 
27. Franklin, M., and M. A. Franklin. 1971. A profile of 
Pseudomonas. The University of New Brunswick, Frederic-
ton, Canada. 
28. Gelbart, S.M., G. F. Reinhardt, and H. B. Greenlee. 
1976. Pseudomonas cepacia strains isolated from water 
reservoirs of unheated nebulizers. J. Clin. Microbial. 
3:62-66. 
· 29. Gerlach, E. H. 1974. Microdilution I: a comparative 
study, p.63-76. In Albert Balows (ed.), Current tech-
niques for antibiotic susceptibility testing. C. C. 
Thomas, Springfield, Il. 
30. Gilardi, G. L. 1970. Characterization of E0-1 strains 
(P. kingii) isolated from clinical specimens and the 
hospital' environment. Appl. Microbial. 20:521-522. 
31. Gilardi, G. L. 1971. Antimicrobial susceptibility as a 
diagnostic aid in the identification of nonfermenting 
gram-negative bacteria. Appl. Microbial.· 22:821-823. 
79'· 
32. Gilardi~ G. L. 1972. Infrequently encountered Pseudo-
. monas sp. causing infection in humans.· Ann. Intern. 
Med. 77:211-215. 
33. Gilardi, G. L. 1976. Ps·eudomorias species in clinical 
microbiology. Mt. Sinai J. Med. 43:710-726. 
34. Hamilton, J. W. Burch, G. Grimmett, K. Orme, D. Brewer, 
R. Frost, and C. Fulkerson. 1973. Successful treat-
ment of Pseudomonas cepacia endocarditis with tri-
methoprim-sulfamethoxazole. Antimicrob. Agents 
Chemother. 4:551-554. 
35. Hardy, P. C., G. M. Ederer, and J. M. Matsen. 1970. 
Contamination of commercially packaged urinary 
catheter kits with the species EO-I. N. Engl. J. Med. 
282:33-35. . 
36. Hugh, R. and E. J. Leifson. 1953. The taxonomic signi-
ficance of fermentative versus oxidative metabolism 
of carbohydrates by various gram negative bacteria. 
J. Bacteriol. 66:24-26. 
37. Hugh, R., and G. L. Gilardi. 1974. Pseudomonas, 
P.250-269. In E. H. Lennett, E. H. Spaulding, and 
J. P. Truant (ed.), Manual of clinical microbiology, 
2nd ed. American Society for Microbiology, Washington, 
D.C. 
38. Jones, R.N., and P. C. Fuchs. 1976. Quantitative anti-
microbic susceptibility testing manual, 2nd ed. 
Micro-Media Systems, San Jose, Ca. 
39 .. Jonsson, V. 1970. Proposal of a new species· P. kingii. 
Inti. J. Syst. Bacteriol. 20:255-257. 
40. King, E. 0. 1964. The identification of unusual patho-
genic gram negative bacteria. National Communicable 
Disease Center, Atlanta, Ga. 
41. Koontz, F. 1969. Workshop manual. Laboratory methods 
for miscellaneous procedures for gram negative 
organisms. State Hygienic Laboratory, University of 
Iowa, Iowa City, Ia. 
42. Kothari, T. , M. P. Reyes, N. Brooks, W. J. Brown, and 
A. M. Lerner. 1977. Pseudomonas cepacia septic arthri-
tis due to intra-articular injections of methylpred-
nisolone. Can. Med. Assoc. J. 116:1230,1232,1235. 
80 
43. MacFaddin, J. F. 1976. Biochemical tests for identifi-
cation of medical bacteria. Williams and Wilkins 
Co.~ Baltimore, Md. 
44. Mandell, N., H. D. Feiner, N. M. Price, and M. 
Simberkoff. 1977. Pseudomonas cepacia endocarditis 
and e·cythyma gangrenosum. Arch. Dermatol. 113:199-202. 
45. Matsen, J. M., and A. L. Barry. 1974. Susceptibility: 
diffusion test procedures, p.418-427. In E. H. Lennett, 
E. H. Spaulding, and J. P. Truant (ed.~ Manual of 
clinical microbiology, 2nd ed. American Society for 
M-icrobiology, Washington, D. C. 
46. Meyer, G. W. 1973. Pseudomonas cepacia septicemia associ~ 
ated with intravenous therapy. Calif. Med. 119:15-18. 
47. Micro-Media Systems, Inc. 1977. Instruction manual for 
microdilution MIC test panels, Campbell, Ca. 
48. Mitchell, R. G., and A. C. Hayward. 1966. Postoperative 
urinary-tract infection caused by contaminated irri-
gating fluid. Lancet 1:793-795. 
49. Moody, M. R., V. M. Young, and D. M. Kenton. 1972. In 
vitro antibiotic susceptibility of pseudomonads other 
than Pseudomonas aeruginosa recovered from cancer 
patients. Antimicrob. Agents Chemother. ~:344-349. 
50. Neu, H. C., G. J. Garvey, and M. P. Beach. 1973(. 
Successful treatment of Pseudomonas cepacia endocardi-
tis in a heroin addict with trimethoprim-sulfa-
methoxazole. J. Infect. Dis. 128Suppl.:S768-S770. 
51. Noriega, E. R., E. Rubinstein, M. S. Simberkoff, and 
J. J. Rahal. 1975. Subacute and acute endocarditis 
due to Pseudomonas cepacia in heroin addicts. Am. J. 
Med. 59:29-36. 
52. Oberhofer, T. R., J. W. Rowen, and G. F. Cunningham. 
1977·. Characterization and identification of gram-
negative, nonfermentative bacteria. J. Clin. Microbial. 
5:208-220. 
53. Paik, G., and M. T. Suggs. 1974. Reagents, stains and 
miscellaneous test procedures. p.930-950. In E. H. 
Lennett, E. H. Spaulding, and J. P. Truant-red.), 
Manual of clinical microbiology, 2nd ed. American 
Society for Microbiology, Washington, D.C. 
81 
54. Palleroni~ N. J. 1975. General properties and taxonomy 
of· the genus Pseudomonas, p .1-36. In P. H. Clarke and 
M. H. Richmond (ed.), Genetics and biochemistry of 
Pseudomonas. John Hiley and Sons, Inc., New York. 
55. Philips, L, S. Eykyn, M.A. Curtis, and J. J. S. Snell. 
1971. Pseudomonas cepacia (mute.:t•vorans) septicemia 
in an intensive care unit. - Lancet 1: 37 5-3 77. 
56. Pickett, M. J., and M. M. Pedersen. 1970. Nonfermenta-
tive bacilli associated with man: II. Detection and 
identification. Am. J. Clin. Pathol. 54; 164 ... 177. 
57. Pickett, M. J., and M. M. Pedersen. 1970. Characteriza-
tion of saccharolytic nonfermentative bacteria associ-
ated with man. Can. J. Microbiol. 16:351-362~ 
58. Pickett, M. J., and M. M. Pedersen. 1970. Salient fea-
tures of nonsaccharolytic and weakly saccharolytic 
nonfermentative rods. Can. J. Microbiol. 16; 401-409. 
59. Poe, R. H., H. R. Marcus, and G. L. Emerson. 1977. Lung 
abscess due to Pseudomonas cepacia. Am. Rev. Respir. 
Dis. 115:861-865. 
60. Rahal, J. J., M. S. Simberkoff, and P. J. Hyams. 1973. 
Pseudomonas cepacia tricuspid endocarditis:treatment 
with trimethoprim, sulfonamide and polymixin B. J. 
Infect. Dis. 128Suppl. : S762-S76 7. 
61. Rapkin, R. H. 1976. Pseudomonas cepacia in an intensive 
care nursery. Pediatrics 57:239-243. 
62. Roberts, J. B. M., and D. C. E. Speller. 1973. Pseudo-
monas cepacia in renal calculi. Lancet 2:1099. 
63. Samuels, S. B., C. W. Moss, and R. E. Weaver. 1973. 
The fatty acids of Pseudomonas multivorans (Pseudo-
monas cepacia) and Pseudomonas kingii. J. Gen. Micro-
bioi. 74:275-279. 
64. Schaffner, W. , G. Reisig, and R. Verrall. 1973. Out-
break of Pseudomonas cepacia infection due to con-
taminated anaesthetics. Lancet 1:1050-1051. 
65. Schiff, J., L. S. Suter, R. D. Gourley, and l-1. D. 
Sutliff. 1961. Flavobacterium infection as a cause 
of bacterial endocarditis: report of a case of 
bacterial studies and review of the literature. Ann. 
Intern. Med. 55:499-506. 
66. Simmons, J. S. 1926. A culture medium for differenti-
ating organisms of typhoid-colon aerogenes group 
and isolation of certain fungi. J. Infect. Dis. 39: 
201-214. 
67. Simmons, N. A. 1970. Colistin, sulphamethoxazole, and 
trimethoprim in syne~gy against gram-negative bac-
teria. J. Clin. Pathol. 23:757-764. 
82 
68. Sorrell, W. B., and L. V. White. 1953. Acute bacterial 
endocarditis caused by a variant of the genus 
Herrelea: report of a. case. Am. J. Clin. Pathol. 23: 
134-138. 
69. Taplin, D., D. C. J. Bassett, and P.M. Mertz. 1971. 
Foot lesions associated with Pseudomonas cepacia. 
Lancet 1:568-571. · 
70. Tatu,m, H. W.,. W. H. Ewing~ and R. E. Weaver. 1974. , 
Miscellp.neous gram-negative bacteria, p.270-294. : 
In E. H. Lennett, E. H. Spaulding, and J. P. Truant 
"{ed.), Manual of clinical microbiology, 2nd ed. 
American Society for Microbiology, Washington, D.C. 
71. Taylor·, t-1. I., and D. A. Achanzar. 1972. Catalase test 
as an aid to the identification of Enterobacteriaceae. 
Appl. Microbial. 24:58-61. 
72. Travenol Labs. 1972. Hospital sepsis - new medcom total 
learning system. Travenol Labs, Inc., Deerfield, Il. 
73. Vice, J. L., and M. F. Smaron. 1973. Indirect fluor-
escent-antibody method for the identification of 
C. vaginale. Appl. Microbiol. 25:908-916. 
74. Weaver, R. E., H. W. Tatum, and D. G. Hollis. 1972. 
The identification of unusual pathogenic gram-nega-
tive bacteria. Preliminary revision. Center for 
Disease Control, Atlanta, Ga. 
75. Weinstein, A. J., R. c. Moellering, C. C. Hopkins, and 
A. Goldblatt. 1973. Case report: Pseudomonas cepacia 
pneumonia. Am. J. Med. Sci. 265:491-494. 
76. Yabuuchi, E., N. Miyajima, H. Hotta, and A. Ohyama. 
1970. Pseudomonas ceEacia from blood of a burn 
patient. Med. J. Osa a Univ. 21:1-6. 
APPROVAL SHEET 
The thesis submitted by Beatrice Miceika has been read and approved by 
the following committee: 
Dr. J. Vice, Director 
Assistant Professor, Microbiology and 
Director, Clinical Microbiology, Loyola 
Dr. C. F. Lange 
Professor, Microbiology, Loyola 
Dr. T. Hashimoto 
Professor, f4icrobiology, Loyola 
Dr. E. Bermes 
Professor, Pathology and Biochemistry, Loyola 
The final copies have been examined by the director of the thesis and 
the signature which appears below verifies the fact that any necessary 
changes have been incorporated and that the thesis is now given final 
approval by the Committee with reference to content and form. 
The thesis is therefore accepted in partial fulfillment of the require-
ments for the degree of Master of Science in Microbiology. 
Director•s S1gnature 
·' ·-··.·':'",··· ..... 
